<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<!--
-->
<!-- %html{'xmlns'=>'http://www.w3.org/1999/xhtml', 'xml:lang'=>'en', 'lang'=>'en'} -->
<html>
<head>
<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"beacon-1.newrelic.com","errorBeacon":"jserror.newrelic.com","licenseKey":"d64d3db899","applicationID":"125361","transactionName":"dAkNQBFbXFUEREkBCVQTDlENQB9dDlUTCANZEkxHC1tH","queueTime":0,"applicationTime":1098,"ttGuid":"","agentToken":null,"agent":"js-agent.newrelic.com/nr-298.min.js","extra":""}</script>
<script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function a(b,c,d){function e(f){if(!c[f]){var g=c[f]={exports:{}};b[f][0].call(g.exports,function(a){var c=b[f][1][a];return e(c?c:a)},g,g.exports,a,b,c,d)}return c[f].exports}for(var f=0;f<d.length;f++)e(d[f]);return e}({"4O2Y62":[function(a,b){function c(a,b){var c=d[a];return c?c.apply(this,b):(e[a]||(e[a]=[]),void e[a].push(b))}var d={},e={};b.exports=c,c.queues=e,c.handlers=d},{}],handle:[function(a,b){b.exports=a("4O2Y62")},{}],YLUGVp:[function(a,b){function c(){var a=m.info=NREUM.info,b=m.proto="https"===l.split(":")[0]||a.sslForHttp?"https://":"http://";if(a&&a.agent&&a.licenseKey&&a.applicationID){f("mark",["onload",e()]);var c=h.createElement("script");c.src=b+a.agent,h.body.appendChild(c)}}function d(){"complete"===h.readyState&&f("mark",["domContent",e()])}function e(){return(new Date).getTime()}var f=a("handle"),g=window,h=g.document,i="readystatechange",j="addEventListener",k="attachEvent",l=(""+location).split("?")[0],m=b.exports={offset:e(),origin:l};h[j]?(h[j](i,d,!1),g[j]("load",c,!1)):(h[k]("on"+i,d),g[k]("onload",c)),f("mark",["firstbyte",e()])},{handle:"4O2Y62"}],loader:[function(a,b){b.exports=a("YLUGVp")},{}]},{},["YLUGVp"]);</script>
<title>
James v. City of Costa Mesa, 684 F.3d 825, 26 AD Cases 412 (9th Cir. 2012), Court Opinion - Bloomberg Law 

</title>
<meta content='NOINDEX, NOFOLLOW' name='ROBOTS'>
<meta content='telephone=no' name='format-detection'>
<meta content='BLAW' name='apple-mobile-web-app-title'>
<meta name="csrf-param" content="authenticity_token"/>
<meta name="csrf-token" content="NiJ+70&#47;qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA="/>
<script src="/min_assets/framework.js?1389213936" type="text/javascript"></script>

<script src="/javascripts/daterange.js?1380743058" type="text/javascript"></script>
<script src="/javascripts/document/document.js?1382459272" type="text/javascript"></script>
<script src="/javascripts/document/document_viewer.js?1383685414" type="text/javascript"></script>
<script src="/javascripts/document/bciteutils.js?1388683076" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.query.js?1342203941" type="text/javascript"></script>
<script src="/javascripts/browser/browser.js?1387565892" type="text/javascript"></script>
<script src="/javascripts/document/image_viewer.js?1366129555" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.selection.js?1375450295" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.bb-copywithcitation.js?1383771008" type="text/javascript"></script>
<script src="/javascripts/document/copy_with_cite.js?1382560939" type="text/javascript"></script>
<script src="/javascripts/document/notepad.js?1366310522" type="text/javascript"></script>

<link href="/stylesheets/yui2/yui2_combo.css?1288273584" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_v2.css?1391022004" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/min_assets/framework.css?1391022047" media="screen,print" rel="stylesheet" type="text/css" />
<!--[if IE]>
<link href="/stylesheets/ie.css?1391022010" media="screen,print" rel="stylesheet" type="text/css" />
<![endif]-->
<link href="/stylesheets/search/search_results.css?1391022036" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document.css?1391022003" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_viewer.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/search/tree_view.css?1391022037" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/browser/browser_enhanced.css?1391021984" media="print,screen" rel="stylesheet" type="text/css" />
<style type='text/css'>
#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6 { font-family:Times New Roman, Times, serif; }
				#content_document pre {
				white-space: pre-wrap;
				white-space: -moz-pre-wrap;
				white-space: -pre-wrap;
				white-space: -o-pre-wrap;
				word-wrap: break-word;
				font-family: Bloomberg Fixed 2 Unicode;
			}
			
			#content_document .page_no { 
				font-weight:bold;
				text-decoration:none;
			}
			
			#content_document .highlight { 
				font-weight:bold; 
				background-color:yellow; 
				color:black;
			}
			
			#content_document .bcitehi { 
				font-weight:bold; 
				background-color:violet; 
				color:black;
			}
			
			/*.UNICODE {
			}
			
			#content_document blockquote {
			}
			
			#content_document em {
			}   
			
			#content_document .tableofcontents {
			}
			
			#content_document div.blockgroup {
			}
			
			#content_document p.opinion_text {
			}  */
			
			#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6, #content_document p, #content_document li, #content_document td, #content_document th, #content_document div {
				font-size: 11pt;
			}
			
			#content_document .main {
				text-align:center; 
				font-weight:bold; 
				color:black;
			}
			
			#content_document .ftnote { 
				font-style:italic;
			}
			
			#content_document .headline {
				font-weight:bold; 
				color:black;
			} 
			
			#content_document p.group{
				padding-top: 0; 
				padding-bottom: 1px; 
				padding-left: 0; 
				padding-right: 0;
				margin-top: 0; 
				margin-bottom: 1px; 
				margin-left: 0; 
				margin-right: 0;
			}
			
			#content_document .big {
				font-size: 13pt;
			}
			
			#content_document .indent {
				text-indent:2.5em;
			}
			
			#content_document .level2 {
				margin-left:2.5em;
				margin-right:2.5em;
			} 
			
			#content_document .level3 {
				margin-left:5em;
				margin-right:5em;
			} 					
			
			#content_document .level4 {
				margin-left:7.5em;
				margin-right:7.5em;
			} 					
			
			#content_document .level5 {
				margin-left:10em;
				margin-right:10em;
			} 					
			
			#content_document .level6 {
				margin-left:12.5em;
			} 					
			
			#content_document a.sup {
				font-size: 6pt; 
				vertical-align: top;
			}
			
			#content_document a.sup1 {
				font-size: 8pt; 
				vertical-align: top;
			}
			
			#content_document em.italic {
				font-style: italic;
			}
			
			#content_document em.bold {
				font-weight: bold;
				font-style: normal;
			}
			
			#content_document em.bold-big {
				font-size: 13pt; 
				font-weight: bold;
			}
			
			#content_document em.underline {
				font-style:normal; 
				text-decoration: underline;
			}
			
			#content_document em.bold-ital {
				font-weight: bold; 
				font-style: italic;
			}
			
			#content_document em.bold-underline {
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.ital-underline {
				font-style: italic; 
				text-decoration: underline;
			}
			
			#content_document em.ital-bold-underline { 
				font-style: italic; 
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document em.strike {
				font-style: normal;
				text-decoration: line-through;
			}
			
			#content_document .small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document h1.organization {
				font-weight: bold; 
				text-align:center; 
				font-style: normal;
			} 
			
			#content_document h2.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:2.5em; 
				margin-right:2.5em;
			}
			
			#content_document h3.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:5em; 
				margin-right:5em;
			}
			
			#content_document h4.organization {
				font-weight: bold;
				text-align:left;
				margin-left:7.5em; 
				margin-right:5em;
			}
			
			#content_document h5.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:10em; 
				margin-right:5em;
			}
			
			#content_document h2.citation {
				font-weight: bold; 
				text-align:left;
			}
			
			#content_document div.blcitation {
				font-size: 7pt; 
				text-align:center;
			}
			
			#content_document .italic {
				font-style:italic;
			}	
			
			#content_document ul.dash {
				list-style-type: none;
			}
			
			#content_document ul.bullet {
				list-style-type: disc;
			}
			
			#content_document ul.none {
				list-style-type: none;
			}
			
			#content_document li.off {
				list-style-type: none; 
			}
			
			#content_document .mypre { 
				font-size: 100%;
			}
			
			#content_document .TOC {
				text-align:left;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}
			
			#content_document .TOC hr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .bluehr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 500;
				text-align: center;
			}
			
			#content_document .tocentry {
				text-indent:-18px;
				padding-left:18px;
				color: #003399;
				font-weight: 700;
			}
			
			#content_document .doctext {  
				margin:0 auto;  
				text-align: left;  
			}				 
			
			#content_document span.PAGE { 
				color: black; 
				font-weight: bold 
			}
			
			#content_document a:link {  	
				color: #003399;  
				font-weight: 700;
			}
			
			#content_document a:visited {  
				color: #660066;   
				font-weight: 700;
			}
			
			#content_document .fn{  
				padding-left: 50 px; 
				font-weight: 550;
			}				
			
			#content_document .fr a:link {  
				color: #003399;  
				font-weight: 600;
			}
			
			#content_document .fr a:visited {  
				color: #660066;  
				font-weight: 600;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 600;
				text-align: center;
			}
			
			#content_document .volume {  
				text-align:center;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}				
			
			#content_document h2.blcitation {
				font-size: 7pt; 
				text-align:center; 
				white-space:nowrap;
			}
			
			#content_document cite.blcitation {
				white-space:nowrap;
			}
			
			#content_document table.page_legend { 
					width: 100px; 
					text-align: left; 
					background-color: white; 
					font-family: Bloomberg Proportional Unicode;
					font-size: 12px
			}
			#content_document div.page_text {  padding-left: 50 px; margin:0 0 0 50px;  text-align: center;  width:100px; font-size: 12px}

			#content_document .smalllinks{  text-align: right;  font-size: 10px;  font-weight: 500;}		
			
			#content_document .opinion_headnotes{
				margin-top:6px;
				margin-bottom:6px;
			}
			
			#content_document .headnote_group{
				padding: 10px 10px 2px 10px;
				background-color: #ECECEC;
				margin-top:4px;
				margin-bottom:10px;
			}
			
			#content_document .headnote_group_header{
				font-weight: bold;
				margin-bottom: 8px;
			}
			
			#content_document .opinion_headnote{
				clear:both;
				padding-bottom: 4px;
				margin-bottom:10px;
			}
			
			#content_document .highlighted_headnote{
				background-color: #FFFF22;
			}
			
			#content_document .headnote_link{
				font-weight:bold;
				text-decoration: none;
			}
			
			#content_document .show_hide_headnotes{
			}
			
			#content_document .clearfix:after {
				clear:both;
				content: ".";
				height:0px;
				display:block;
				visibility:hidden;
			}
			
			/* BNA Headnotes */
			
			#content_document .headnotesContainer {
				margin: 12px 0;
				padding: 12px 0;
				border-top: 1px solid #000;
				border-bottom: 1px solid #000;
			}
			
			#content_document .headnotesContainer .headnotesContainerTitle {
				font-size: 16px;
				font-weight: bold;
				text-align: center;
			}
			
			#content_document .headnotesContainer .headnoteTitle {
				padding: 8px 12px;
				background-color: #dedede;
				margin: 24px 0 0 0;
				font-size: 16px;
				font-weight: bold;
				text-transform: uppercase;
			}
			
			#content_document .headnotesContainer .headnote {
				margin-left: 24px;
			}
			
			#content_document .headnotesContainer .headnote .headnoteSlug {
				margin-top: 12px;
				font-size: 16px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteDescriptor {
				margin-top: 12px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteToggle .headnoteText {
				margin-bottom: 12px;
			}
		
</style>
<link href="/stylesheets/yui_calendar.css?1391022047" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/docviewer_overrides.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />

<link href="/stylesheets/print.css?1391022029" media="print" rel="stylesheet" type="text/css" />
<link href='/images/favicon.ico' rel='shortcut icon'>
</head>
<body class='securities  document '>
<div class='container'>
<div id='page_loader'></div>
<div class='printHeader printOnly'>
<img src='/images/print_header.jpg'>
<div class='user'>
<span>
Prepared for: Susan Yeh
</span>
</div>
</div>
<div class='topBarHolder printHide'>
<div class='topBar'>
<ul class='topBarElements'>
<li class='skip'>
<a href="#primary_content" tabindex="1">Skip Navigation</a>
</li>
<li class='logout'>
<a href="/log_out.htm" id="logoutButton" onclick="generateExplicitLogoutEvent();">Logout</a>
</li>
<li id='help'>
<a href="/help" target="_blank">Help</a>

</li>
<li id='user'>
<a href="/settings">Susan Yeh</a>

</li>
<li class='withNotifications' id='client_matter'>
<div class='clientMatterDropDown'>
<div>Client Matter</div>
<div class='skinButton blueAlert' style='display:none'>
<span id='currentClientMatter'>

</span>
</div>
<span class='noneSelected' style=''>
&nbsp;(None Selected)
</span>
<div class='expandable'></div>
</div>
<div class='topNavDropdown' id='sub_client_matter'>
<ul>
<li style='display:none'>
<a class='remove_client_matter_menu_item' href='#' onclick='return true;' title='Remove Current Client Matter'>
Remove Current Client Matter
</a>
</li>
<li>
<a class='enter_client_matter_menu_item' href='#' onclick='return true;' title='Enter Client Matter'>
Enter Client Matter
</a>
</li>
</ul>
</div>

</li>
<li class='withNotifications' id='alerts'>
<a href="/alerts/inbox"><div id='unreadAlertsCount'>
Saved Searches & Alerts
</div>
</a>
</li>
<li class='withNotifications' id='downloads'>
<a href="/download/download_center"><div id='unreadDownloadsCount'>
<div>Downloads</div>
</div>
</a>
</li>
<li id='research_trail'>
<a href="/research_trail"><div>Research Trail</div>
</a>
</li>
<li id='workspaces'>
<a href="/workspaces"><div>Workspaces</div>

</a></li>
</ul>
</div>
</div>

<div class='topMenu textBkDark printHide' id='top_menu'>
<div class='contextHolder'>
<a href='/home'>
<h1 class='logo'></h1>
</a>
<div class='menuRow'>
<ul class='menuItems'>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_HOME' onclick="javascript:navigation_selectMenuItem('HOME');">
Home
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button active' id='nav_menu_button_search' onclick="javascript:navigation_selectMenuItem('search');">
Search & Browse
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_practice_areas' onclick="javascript:navigation_selectMenuItem('practice_areas');">
Practice Centers
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LITIGATION' onclick="javascript:navigation_selectMenuItem('LITIGATION');">
Litigation & Dockets
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_transactional' onclick="javascript:navigation_selectMenuItem('transactional');">
Transactional Law
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LEG_REG' onclick="javascript:navigation_selectMenuItem('LEG_REG');">
Legislative & Regulatory
</a>
</li>
<li class='legalAnalysis' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_news' onclick="javascript:navigation_selectMenuItem('news');">
Legal Analysis & News
</a>
</li>
<li class='last' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_market' onclick="javascript:navigation_selectMenuItem('market');">
Companies & Markets
</a>
</li>

</ul>
</div>
<form accept-charset="UTF-8" action="/autocomplete/jump" id="search_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id='quicksearch_context' name='context_value' type='hidden' value='PRACTICE'>
<div class='searchBox' id='quick_search'>
<div class='inputContainer'>
<input autocomplete='off' id='quick_search_term' name='term' onkeydown='framework_handleTextInput(event,quick_search_term)' tabindex='2' type='text'>
<div class='searchButton' onmouseup='return framework_activateForm();' tabindex='3'></div>
<a href="/help/BLAWHelpSystem.htm#GO_Using_the_GO_BAR.htm" class="infoBtn" target="_blank" title="Using the &lt;GO&gt; Bar"></a>
<input id='quick_search_post' name='qs_type' type='hidden' value='general'>
<input id='quick_search_type' name='type' type='hidden' value='input_terms'>
<input id='quick_search_value' name='item_value' type='hidden'>
<input id='quick_search_origin' name='search_type' type='hidden' value='LAW'>
</div>
</div>
</form>


</div>
</div>

<div class='main clearfix'>
<div class='menuDrawer'>
<div class='interior'>
<div class='drawer_shade drawerShade clearfix'>
<div class='dropShadow'></div>
<div class='sub_menu subMenu' id='sub_menu_HOME'>
<table>
<tr>
<td class=''>
<ul>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_search'>
<div class='subTitles'>
<div class='subItem one '>
Search
</div>
<div class='subItem two '>
Specialized Searches
</div>
<div class='subItem one last'>
Browse
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/legal_search'>
<div class='navLinkTitle'>
All Legal Content
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Court Opinions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dnds_search'>
<div class='navLinkTitle'>
Domain Name Decisions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
News
</div>
</a>
</li>
<li>
<a class='clearfix' href='/patent_search'>
<div class='navLinkTitle'>
Patents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/people_search'>
<div class='navLinkTitle'>
People
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Regulatory
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/no_action_search'>
<div class='navLinkTitle'>
SEC No-Action Letters
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.293113'>
<div class='navLinkTitle'>
Federal Law
</div>
</a>
</li>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Law
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_practice_areas'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/antitrust'>
<div class='navLinkTitle'>
Antitrust
</div>
</a>
</li>
<li>
<a class='clearfix' href='/banking_finance'>
<div class='navLinkTitle'>
Banking & Finance
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/bankruptcy'>
<div class='navLinkTitle'>
Bankruptcy
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/corporate_ma'>
<div class='navLinkTitle'>
Corporate/M&A
</div>
</a>
</li>
<li>
<a class='clearfix' href='/employee_benefits'>
<div class='navLinkTitle'>
Employee Benefits
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/health'>
<div class='navLinkTitle'>
Health
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/ip_law'>
<div class='navLinkTitle'>
Intellectual Property
</div>
</a>
</li>
<li>
<a class='clearfix' href='/labor_employment'>
<div class='navLinkTitle'>
Labor & Employment
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/securities'>
<div class='navLinkTitle'>
Securities
</div>
</a>
</li>
<li>
<a class='clearfix' href='/tax'>
<div class='navLinkTitle'>
Tax
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LITIGATION'>
<div class='subTitles'>
<div class='subItem two '>
Litigation
</div>
<div class='subItem two last'>
Dockets
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Search Court Opinions
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_menu/X7TO28O'>
<div class='navLinkTitle'>
BNA Outlines & Headnotes
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.103000'>
<div class='navLinkTitle'>
Federal Rules
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/general'>
<div class='navLinkTitle'>
Litigation Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Search Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/breaking'>
<div class='navLinkTitle'>
Breaking Complaints
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/analytics'>
<div class='navLinkTitle'>
Docket Analytics
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dockets/coverage'>
<div class='navLinkTitle'>
Docket Coverage
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/requests'>
<div class='navLinkTitle'>
Docket Requests
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/tracking'>
<div class='navLinkTitle'>
Docket Tracking
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_transactional'>
<div class='subTitles'>
<div class='subItem two '>
Search
</div>
<div class='subItem two last'>
Resources
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/example_and_saved_searches'>
<div class='navLinkTitle'>
Example Searches
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dealmaker_clause_search'>
<div class='navLinkTitle'>
DealMaker Clauses
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/deal_maker/current_awareness'>
<div class='navLinkTitle'>
Current Awareness
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_menu/X7TS80O'>
<div class='navLinkTitle'>
Drafting Guides & Overviews
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_menu/X7TVS0O'>
<div class='navLinkTitle'>
Transactional Legal Treatises
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/deal_maker/resources'>
<div class='navLinkTitle'>
Transactional Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LEG_REG'>
<div class='subTitles'>
<div class='subItem two '>
Legislative
</div>
<div class='subItem two last'>
Regulatory
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Search Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/leg_search/congressional_bill_search'>
<div class='navLinkTitle'>
Search Congressional Bills
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24221'>
<div class='navLinkTitle'>
U.S. Code
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Legislative Materials
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/leg_news_analysis'>
<div class='navLinkTitle'>
Legislative Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Search Regulatory
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search/federal_register_search'>
<div class='navLinkTitle'>
Search Federal Register
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24230'>
<div class='navLinkTitle'>
Code of Federal Regulations
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Regulatory Materials
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_updates'>
<div class='navLinkTitle'>
Monitor Regulators
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/reg_news_analysis'>
<div class='navLinkTitle'>
Regulatory Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_news'>
<div class='subTitles'>
<div class='subItem two '>
Legal Analysis
</div>
<div class='subItem two last'>
News
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
Search News
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/news'>
<div class='navLinkTitle'>
Legal News
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/news/topic'>
<div class='navLinkTitle'>
News by Topic
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/top_news'>
<div class='navLinkTitle'>
TOP News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_market'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/business_development'>
<div class='navLinkTitle'>
Business Development Center
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
Search EDGAR
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company'>
<div class='navLinkTitle'>
Company Watchlist
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li class='last'>
<a class='clearfix' href='/report_writer'>
<div class='navLinkTitle'>
Company Report Writer
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/market'>
<div class='navLinkTitle'>
Market News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>

</div>
</div>
<div class='bottomFlange'></div>
</div>
<div class='breadcrumbContainer printHide'>
<div class='breadHolder'>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_0'>
Search & Browse
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_1'>
<a href='/conversion/resolve_search/2cca9bfdd71c4fe272702f69d32bd070'>
Court Opinions
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_2'>
<a href='/opinion_search/results/2cca9bfdd71c4fe272702f69d32bd070'>
Search Results
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
</div>
</div>

</div>
<div class='page clearfix'>
<div class='content' id='page_content'>
<div id='statusHolder'></div>
<a name='primary_content'></a>
<div class='document_search_links_container printHide'>
<div class='prev_search_result_container'>
<div class='attachmentPanelBackButton' onclick="document.location = $('.prev_search_result_link a').attr('href')"></div>
<div class='prev_search_result_link'>
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1HOB4I003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="{}" data-doc-id="X1HOB4I003">Previous Result: <span>Swanigan v. Quality Cabinet Work, LLC, C...</span></a>
<div class='clearfix'></div>
</div>
</div>
<div class='next_search_result_container'>
<div class='next_search_result_link'>
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1HOB8Q003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="{}" data-doc-id="X1HOB8Q003">Next Result: <span>Allicock v. United States, CASE NO. 3:09...</span></a>
<div class='clearfix'></div>
</div>
<div class='attachmentPanelForwardButton' onclick="document.location = $('.next_search_result_link a').attr('href')"></div>
</div>
<div class='clearfix'></div>
</div>
<div class='clearfix'></div>

<div class='breadCrumbTitleRow clearfix eight grid'>
<div class="icon citation caution" title="Caution"></div>
<div class='title left' title='James v. City of Costa Mesa, 684 F.3d 825, 26 AD Cases 412 (9th Cir. 2012), Court Opinion'>
James v. City of Costa Mesa, 684 F.3d 825, 26 AD Cases 412 (9th Cir. 2012), Court Opinion
</div>
</div>

<div class='metadata' style='display: none'>
<div class='documentTitle'>James v. City of Costa Mesa, 684 F.3d 825, 26 AD Cases 412 (9th Cir. 2012), Court Opinion</div>
<div class='docId'>X1HOAG0003</div>
<div class='docType'>OPINIONS</div>
<div class='case_name'>James v. City of Costa Mesa</div>
<div class='displayCitation'>2012 BL 123718</div>
<div class='displayCitation'>684 F.3d 825</div>
<div class='displayCitation'>bna 26 adcases 412</div>
<div class='displayCitation'>bna a0d2n8n2r4</div>
<div class='displayCitation'>bna a0d2u3t7d0</div>
<div class='displayCitation'>bna a0d5f6h0y3</div>
<div class='displayCitation'>wkf9case:26088704</div>
</div>

<div class='search_outline_node_popup' style='display:none'>
<form accept-charset="UTF-8" action="/document/class_outline_search" id="search_document_node_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>Search</h2>
</div>
<p class='searchOver'>
Search over:
<span class='search_target_node'></span>
<input class="search_source_id" id="source_id" name="source_id" type="hidden" />
<input class="search_node_id" id="search_node_id" name="search_node_id" type="hidden" />
<input class="search_service_code" id="search_service_code" name="search_service_code" type="hidden" />
<input class="search_division" id="search_division" name="search_division" type="hidden" />
<input autocomplete="off" class="search_node_text" id="search_term" name="search_term" type="text" />
</p>
<div class='clearfix'></div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right print' onclick='this.form.submit();'>
<span>
Search
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

</div>
<div id='no_matching_keywords_popup' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>No Matches Found</h2>
</div>
<p>
Search term(s) not found.
</p>
<div class='popUpActions'>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>
<div id='copyWithCitationPopupContents' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>Copy with Citation</h2>
</div>
<p>
Copy the text below to paste into your document.
</p>
<div class='clearfix'>
<div class='copyWithCitationScrollBox'>
<div class='copyWithCitationArea left'>
<div class='copyWithCitationText'></div>
<div class='copyWithCitationDocumentTitle'></div>
</div>
<div class='ie9compat left'>
<img alt="" src="/images/transparency.png?1296705112" width="1" />
</div>
</div>
</div>
<div class='copyWithCitationCheckBoxHolder'>
<input checked="checked" class="linkCitation" id="link_citation" name="link_citation" onclick="updateCopyWithCitationLinks()" type="checkbox" value="true" />
Link citations to Bloomberg Law
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>

<script type='text/javascript'>
  //<![CDATA[
    $('#page_content').addClass("invisible");
  //]]>
</script>
<input id="doc_id" name="doc_id" type="hidden" value="X1HOAG0003" />
<input id="hidden_document_title" name="hidden_document_title" type="hidden" value="James v. City of Costa Mesa, 684 F.3d 825, 26 AD Cases 412 (9th Cir. 2012), Court Opinion" />
<input id="hidden_case_name" name="hidden_case_name" type="hidden" value="James v. City of Costa Mesa" />
<input id="hidden_case_docket" name="hidden_case_docket" type="hidden" />
<div class='toolHolder'>
<form accept-charset="UTF-8" action="" id="downloadPopupLinkForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div><input id="pde_location_type" name="pde_location_type" type="hidden" value="DOCUMENT" /><input id="full_doc_path" name="full_doc_path" type="hidden" value="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1HOAG0003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="document_type" name="document_type" type="hidden" value="OPINIONS" /><input id="doc_id" name="doc_id" type="hidden" value="X1HOAG0003&amp;search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="artifact_id" name="artifact_id" type="hidden" value="X1HOAG0003" /><input id="title" name="title" type="hidden" value="James v. City of Costa Mesa, 684 F.3d 825, 26 AD Cases 412 (9th Cir. 2012), Court Opinion" /><input id="search32" name="search32" type="hidden" value="DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="citation_analysis" name="citation_analysis" type="hidden" value="CAUTION" /><input id="context_resource_id" name="context_resource_id" type="hidden" value="2cca9bfdd71c4fe272702f69d32bd070" /><input id="has_sidebar_info" name="has_sidebar_info" type="hidden" value="true" /><input id="tab_types_" name="tab_types[]" type="hidden" value="TAB_OPINION" /><input id="has_notepad" name="has_notepad" type="hidden" value="true" /><input id="notepad_id" name="notepad_id" type="hidden" value="X1HOAG0003" /><input id="has_headnotes" name="has_headnotes" type="hidden" value="true" /><input id="preselect_option" name="preselect_option" type="hidden" value="DOCUMENT" /></form>

<ul class='tools printHide'>
<li>
<a href="#" onclick="javascript:quickPrintLink(); return false;">Quick Print</a>

</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('download','downloadPopupLinkForm'); return false;">Print/Download</a>
</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('email','downloadPopupLinkForm'); return false;">Email</a>
</li>
<li>
<a href="#" onclick="javascript:addPopupForm('add_to_workspace','?resource_path=%2Fs%2Fopinion%2F%32cca%39bfdd%37%31c%34fe%32%37%32%37%30%32f%36%39d%33%32bd%30%37%30%2Fdocument%2FX%31HOAG%30%30%30%33%3Fsearch%33%32%3DDPNLUQBDE%31FN%30Q%33IC%35PMASPT%36%34TJMSRPDPNMSUBDECUJ%32&amp;document_type=OPINIONS', null); return false;">+ Workspace</a>
</li>
<li>
<a onclick='javascript:PDETray_default.addSelection();'>
+ Queue
</a>
</li>
<li class='last'></li>
</ul>
</div>

<div class='bootstrap printHide tabs'>
<a class='borderTab activeTab' id='tab_DOCUMENT'>
Document
</a>

<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/bcite/X1HOAG0003/history" class="borderTab inactiveTab" id="tab_HISTORY" onclick="docTabSpinner()">Direct History</a>

<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/bcite/X1HOAG0003/analysis" class="borderTab inactiveTab" id="tab_ANALYSIS" onclick="docTabSpinner()">Case Analysis</a>

<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/bcite/X1HOAG0003/toa" class="borderTab inactiveTab" id="tab_TOA" onclick="docTabSpinner()">Table of Authorities</a>

<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/related_content/X1HOAG0003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="borderTab inactiveTab" id="tab_CITING_DOCS" onclick="docTabSpinner()">Citing Documents</a>

<div class='showHide printHide'>
<div class='showHideSidebarArrow'>
<a class='bliderText' id='bliderLink'>
<span id='bliderText'>
Hide General Info & Notepad
</span>
<span id='notepadCountLabel'></span>
</a>
</div>
</div>

</div>

<!-- document -->
<script type='text/javascript'>
  //<![CDATA[
    var fluid_layout=false;
  //]]>
</script>

<!-- %table.markupContainment -->
<!-- %tbody -->
<!-- %tr -->
<!-- %td#markup_holder{:valign=>"top", :align=>"left"} -->
<div class='docHolder legal hasSearchTerms ' id='doc_holder'>
<div class='documentContent ' id='content_document'>


<script type="text/javascript">
					function Blaw__Citator()
					{
						window.location="bloomberg:bcite_url_prefix=/rest/documents/1709749305347";
					}
				</script><script type="text/javascript">
      var BLAW_TOTAL_KEYWORD = 0;
      var BLAW_CURRENT_KEYWORD = -1;
      var BLAW_LAST_COLOR = "yellow";
      var BLAW_ANCHOR_NAME = "blawkeyword";
      var BLAW_BASE_URL = document.location.href;

      function Blaw__changeCurElem(lastAnchor, newAnchor)
      {
        var baseUrl = Blaw__getBaseURL(document.location.href);
        document.location.href = baseUrl + "#" + newAnchor;
        var elem = document.getElementById(lastAnchor)[0];
        if (elem) {
          elem.style.backgroundColor = BLAW_LAST_COLOR;
        }
        elem = document.getElementById(newAnchor)[0];
        if (elem) {
          BLAW_LAST_COLOR = elem.style.backgroundColor;
          elem.style.backgroundColor = "orange";
        }
      }

      function Blaw__findNextKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (++BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }

        // if index does not exist on page continue to inc until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD < BLAW_TOTAL_KEYWORD) {
            ++BLAW_CURRENT_KEYWORD;
            // wrap around search, once only
            if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD && !looped) {
              BLAW_CURRENT_KEYWORD = 0;
              looped = true;
            }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findPrevKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (--BLAW_CURRENT_KEYWORD < 0) {
          BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
          looped = true;
        }

        // if index does not exist on page continue to decr until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD >= 0) {
          --BLAW_CURRENT_KEYWORD;
          // wrap around search, once only
          if (BLAW_CURRENT_KEYWORD < 0 && !looped) {
            BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
            looped = true;
          }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findNextFrom(indx)
      {
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        BLAW_CURRENT_KEYWORD = indx;
        ++BLAW_CURRENT_KEYWORD;
        if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__getBaseURL(url)
      {
        var reg = new RegExp("(.+)#.+$");
        var ar = reg.exec(url);
        if (ar != null) {
          return ar[1];
        } else {
          return url;
        }
      }


    </script><div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="metadata" style="display: none">
<div class="pagination_series_list">PrimaryFederalReporter,Bloomberg,</div>
<div class="citation-group">
<div class="cite" data-cite-type="PrimaryFederalReporter">684 F.3d 825</div>
<div class="cite" data-cite-type="DocketNumber">10-55769</div>
<div class="cite" data-cite-type="Bloomberg">2012 BL 123718</div>
</div>
</div>
<div align="left" class="tableofcontents">
<br CLEAR="right"><div class="page_text" style="float:right">
<b>Pagination</b><table class="page_legend" cellspacing="0">
<tr>
<td width="25%" align="left" valign="top">*</td>
<td width="50%" align="left" valign="top">F.3d </td>
</tr>
<tr>
<td width="25%" align="left" valign="top">**</td>
<td width="50%" align="left" valign="top">BL</td>
</tr>
</table>
</div>
<br>
</div>
<table><tbody><tr><td>&nbsp;</td></tr></tbody></table>
<p><center>
United States Court of Appeals, Ninth Circuit.
</center></p>
<hr align="center" width="65%">
<p><center>
Marla JAMES; Wayne Washington; James Armantrout; Charles Daniel Dejong,
Plaintiffs-Appellants, v. CITY OF COSTA MESA, a city incorporated under the
laws of the State of California; City of Lake Forest, a city incorporated
under the laws of the State of California, Defendants-Appellees.
</center></p>
<hr align="center" width="65%">
<p><center>
No. 10-55769.
</center></p>
<p><center>
Argued and Submitted May 6, 2011.
</center></p>
<p><center>
May 21, 2012.
<span CLASS="page_no" data-cite="684 f 3d 827" data-cite-type="PrimaryFederalReporter" data-cite-pageno="827" data-primary-citation="684 F.3d 825">[*827]</span> </center></p>
<div class="headnotesToggle clearfix"><button id="toggle_headnotes_button" class="bootstrap skinButton sourceButton wide right hideSource" data-target="#headnotes_container"><span>Hide Headnotes</span></button></div>
<div class="headnotesContainer" id="headnotes_container">
<div class="headnotesContainerTitle">BNA Headnotes</div>
<div class="headnoteTitle"><a href="http://www.bloomberglaw.com/document/1475563767425280">Americans with Disabilities</a></div>
<div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="headnote">
<div class="headnoteSlug">AMERICANS WITH DISABILITIES ACT </div>
<div class="headnoteDescriptor">
<a name="headnote_lrac-dec_915349" href="#headnote_ref_lrac-dec_915349">[1]</a> <span>Title II &mdash; Medical use of marijuana </span> <a href="http://www.bloomberglaw.com/document/1709749305347/class_outline_search?source_id=105.455832&amp;search_service_code=adco-ref&amp;search_node_id=106.0433" rel="ref" data-source-id="105.455832" data-service-code="adco-ref" data-node-id="106.0433">&#9658;106.0433</a> <a href="http://www.bloomberglaw.com/document/1709749305347/class_outline_search?source_id=105.455832&amp;search_service_code=adco-ref&amp;search_node_id=403.01" rel="ref" data-source-id="105.455832" data-service-code="adco-ref" data-node-id="403.01">&#9658;403.01</a> <a href="http://www.bloomberglaw.com/document/1709749305347/class_outline_search?source_id=105.455832&amp;search_service_code=adco-ref&amp;search_node_id=411.01" rel="ref" data-source-id="105.455832" data-service-code="adco-ref" data-node-id="411.01">&#9658;411.01</a> <a href="http://www.bloomberglaw.com/document/1709749305347/class_outline_search?source_id=105.455832&amp;search_service_code=adco-ref&amp;search_node_id=444.01" rel="ref" data-source-id="105.455832" data-service-code="adco-ref" data-node-id="444.01">&#9658;444.01</a> <a href="http://www.bloomberglaw.com/document/1709749305347/class_outline_search?source_id=105.455832&amp;search_service_code=adco-ref&amp;search_node_id=471.01" rel="ref" data-source-id="105.455832" data-service-code="adco-ref" data-node-id="471.01">&#9658;471.01</a> <a href="http://www.bloomberglaw.com/document/1709749305347/class_outline_search?source_id=105.455832&amp;search_service_code=adco-ref&amp;search_node_id=700.15" rel="ref" data-source-id="105.455832" data-service-code="adco-ref" data-node-id="700.15">&#9658;700.15</a> <span class="headnoteToggle">[<a href="#headnote_content_adcoref_1" data-source-id="105.455832" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_adcoref_1" class="headnoteContent"></div>
<div class="headnote_text">
California medical marijuana users' action alleging that cities' closure of dispensing collectives violated Title II of ADA was properly dismissed, where physician-approved marijuana use permitted under state law is nonetheless excluded from ADA protection as illegal use of drugs as defined by federal Controlled Substances Act, is not subject to ADA's supervised use exception, and congressional action in allowing District of Columbia to implement local medical marijuana initiative did not authorize such use under federal law or violate equal protection.</div>
</div>
</div>
<script type="text/javascript">
					jQuery(function($) {
						$('#toggle_headnotes_button').click(document_toggleHeadnoteVisibility);
					});
				</script><div id="para2" printdualcolumn="true"><p>
Matthew Pappas, Law Office of Matthew Pappas, Mission Viejo, CA, for the
appellants.
</p></div>
<div id="para2" printdualcolumn="true"><p>
James R. Touchstone and Krista MacNevin Jee, Jones &amp; Meyer, Fullerton, CA,
for appellee City of Costa Mesa.
</p></div>
<div id="para2" printdualcolumn="true"><p>
Jeffrey V. Dunn (argued), Daniel S. Roberts and Lee Ann Meyer, Best Best &amp;
Krieger LLP, Irvine, CA, for appellee City of Lake Forest.
</p></div>
<div id="para2" printdualcolumn="true"><p>
Thomas E. Perez and Tony West, Assistant Attorneys General, and Mark L.
Gross and Roscoe Jones, Jr., Attorneys, Department of Justice, Washington,
D.C., for the United States as amicus curiae.
</p></div>
<div id="para2" printdualcolumn="true"><p>
Appeal from the United States District Court for the Central District of
California, Andrew J. Guilford, District Judge, Presiding. D.C. No.
8:10-cv-00402-AG-MLG.

</p></div>
<div id="para2" printdualcolumn="true"><p>
[EDITORS' NOTE: THIS PAGE CONTAINED HEADNOTES AND HEADNOTES ARE NOT AN
OFFICIAL PRODUCT OF THE COURT, THEREFORE THEY ARE NOT DISPLAYED.]
</p></div>
<div id="para2" printdualcolumn="true"><p>
Before: HARRY PREGERSON, RAYMOND C. FISHER and MARSHA S. BERZON, Circuit
Judges.
</p></div>
<div id="contentOpinion" printdualcolumn="true"><div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>OPINION</b>
</p></div></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  FISHER, Circuit Judge:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Opinion by Judge FISHER; Partial Concurrence and Partial Dissent by Judge
BERZON.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The plaintiffs are severely disabled California residents. They alleged
that "[c]onventional medical services, drugs and medications" have not
alleviated the pain caused by their impairments. Each of them has therefore
"obtained a recommendation from a medical doctor" to use marijuana to treat
her pain. This medical marijuana use is permissible under California law,
<i>see</i>Cal. Health &amp; Safety Code &sect; <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XCUJKU003?jcsearch=Cal.%20Health%20%26%20Safety%20Code%20%2011362.5(d)&amp;summary=yes#jcite">11362.5</a>(d) (suspending state-law penalties
for marijuana possession and cultivation for seriously ill Californians and
their caregivers who "possess[] or cultivate[] marijuana for the personal
medical purposes of the patient upon the written or oral recommendation or
approval of a physician"), but prohibited by the federal Controlled
Substances Act (CSA), <i>see</i><a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1976CA003?jcsearch=21%20U.S.C.%20%C2%A7%20812(b)(1)(B)&amp;summary=yes#jcite">21 U.S.C. &sect; 812(b)(1)(B)</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1976CA003?jcsearch=21%20U.S.C.%20%20812(c)(10)&amp;summary=yes#jcite">812(c) sched. I(c)(10)</a>,
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1976D8003?jcsearch=21%20U.S.C.%20%20841(a)&amp;summary=yes#jcite">841(a)</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1976DE003?jcsearch=21%20U.S.C.%20%20844(a)&amp;summary=yes#jcite">844(a)</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The plaintiffs obtain medical marijuana through collectives located in
Costa Mesa and Lake Forest, California. These cities, however, have taken
steps to close marijuana dispensing facilities operating within their
boundaries. Costa Mesa adopted an ordinance excluding medical marijuana
dispensaries completely in 2005. <i>See</i>Costa Mesa, Cal., Ordinance 05-11 (July
19, 2005). Some marijuana dispensing facilities, including the Costa Mesa
collectives, have apparently continued to operate despite the ordinance, but
the plaintiffs alleged that Costa Mesa police have recently "raided
operating marijuana collectives and detained collective members."<a HREF="#fn100" name="fnref_fn100">[fn1]</a>Lake
Forest has also allegedly raided medical marijuana collectives operating
within city limits, and has brought a public nuisance action in state court
seeking to close them. <i>See City of Lake Forest v. Moen</i>, <cite>No. 30-2009-298887</cite>
(Orange Cnty.Super.Ct. filed Sept. 1, 2009).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Concerned about the possible shutdown of the collectives they <span CLASS="page_no" data-cite="2012 bl 123718 p 2" data-cite-type="Bloomberg" data-cite-pageno="2" data-primary-citation="">[**2]</span> rely on to
obtain medical marijuana, the plaintiffs brought
<span CLASS="page_no" data-cite="684 f 3d 828" data-cite-type="PrimaryFederalReporter" data-cite-pageno="828" data-primary-citation="684 F.3d 825">[*828]</span> 
this action in federal district court, alleging that the cities' actions
violate Title II of the Americans with Disabilities Act (ADA), which
prohibits discrimination in the provision of public services.<a HREF="#fn200" name="fnref_fn200">[fn2]</a>District
Judge Guilford sympathized with the plaintiffs, but denied their application
for preliminary injunctive relief on the ground that the ADA does not
protect against discrimination on the basis of marijuana use, even medical
marijuana use supervised by a doctor in accordance with state law, unless
that use is authorized by federal law.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We affirm. We recognize that the plaintiffs are gravely ill, and that
their request for ADA relief implicates not only their right to live
comfortably, but also their basic human dignity. We also acknowledge that
California has embraced marijuana as an effective treatment for individuals
like the plaintiffs who face debilitating pain. Congress has made clear,
however, that the ADA defines "illegal drug use" by reference to federal,
rather than state, law, and federal law does not authorize the plaintiffs'
medical marijuana use. We therefore necessarily conclude that the
plaintiffs' medical marijuana use is not protected by the ADA.<a HREF="#fn300" name="fnref_fn300">[fn3]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  DISCUSSION
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <a id="headnote_ref_lrac-dec_915349" href="#headnote_lrac-dec_915349">[1]</a> Title II of the ADA prohibits public entities from denying the benefit of
public services to any "qualified individual with a disability."
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJK9K003?jcsearch=42%20usc%2012132&amp;summary=yes#jcite">42 U.S.C. &sect; 12132</a>.<a HREF="#fn400" name="fnref_fn400">[fn4]</a>The plaintiffs alleged that, by interfering with
their access to the medical marijuana they use to manage their impairments,
Costa Mesa and Lake Forest have effectively prevented them from accessing
public services,
<span CLASS="page_no" data-cite="684 f 3d 829" data-cite-type="PrimaryFederalReporter" data-cite-pageno="829" data-primary-citation="684 F.3d 825">[*829]</span> 
in violation of Title II. As the district court recognized, however, the ADA
also provides that "the term `individual with a disability' does not include
an individual who is currently engaging in the illegal use of drugs, when
the covered entity acts on the basis of such use." <i><cite>Id</cite>.</i><a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%20%2012210(a)&amp;summary=yes#jcite">&sect; 12210(a)</a>. This case
turns on whether the plaintiffs' medical marijuana use constitutes "illegal
use of drugs" under <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%20%2012210&amp;summary=yes#jcite">&sect; 12210</a>.<a HREF="#fn500" name="fnref_fn500">[fn5]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%20%2012210(d)(1)&amp;summary=yes#jcite">Section 12210(d)(1)</a> defines "illegal use of drugs" as
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      the use of drugs, the possession or distribution of which is
    unlawful under the Controlled Substances Act. Such term does not
    include the use of a drug taken under supervision by a licensed
    health care professional, or other uses authorized by the Controlled
    Substances Act or other provisions of Federal law.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<i><cite>Id</cite>.</i><a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%20%2012210(d)(1)&amp;summary=yes#jcite">&sect; 12210(d)(1)</a>. The parties agree that the possession and distribution of
marijuana, even for medical purposes, is generally unlawful under the CSA,
and thus that medical marijuana use falls within the exclusion set forth in
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%20%2012210(d)(1)&amp;summary=yes#jcite">&sect; 12210(d)(1)</a>'s first sentence. They dispute, however, whether medical
marijuana use is covered by one of the exceptions in the second sentence of
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%20%2012210(d)(1)&amp;summary=yes#jcite">&sect; 12210(d)(1)</a>. The plaintiffs contend their medical marijuana use falls
within the exception for drug use supervised by a licensed health care
professional. They alternatively argue that the exception for drug use
"authorized by . . . other provisions of Federal law" applies. We consider
each argument in turn.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>I.</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We first decide whether the plaintiffs' marijuana use falls within <span CLASS="page_no" data-cite="2012 bl 123718 p 3" data-cite-type="Bloomberg" data-cite-pageno="3" data-primary-citation="">[**3]</span> <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%2012210&amp;summary=yes#jcite">&sect;
12210</a>'s supervised use exception.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  There are two reasonable interpretations of <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%2012210(d)(1)&amp;summary=yes#jcite">&sect; 12210(d)(1)</a>'s language
excepting from the illegal drug exclusion "use of a drug taken under
supervision by a licensed health care professional, or other uses authorized
by the Controlled Substances Act or other provisions of Federal law." The
first interpretation &mdash; urged by the plaintiffs &mdash; is that this language
creates <i>two</i>exceptions to the illegal drug exclusion: (1) an exception for
professionally supervised drug use carried out under <i>any</i>legal authority; and
(2) an independent exception for drug use authorized by the CSA or other
provisions of federal law. The second interpretation &mdash; offered by the cities
and adopted by the district court &mdash; is that the provision contains a
<i>single</i>exception covering all uses authorized by the CSA or other provisions
of federal law, including both CSA-authorized uses that involve professional
supervision (such as use of controlled substances by prescription, as
authorized by <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1976D2003?jcsearch=21%20usc%20829&amp;summary=yes#jcite">21 U.S.C. &sect; 829</a>, and uses of controlled substances in
connection with research and experimentation, as authorized by
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1976CM003?jcsearch=21%20U.S.C.%20%20823(f)&amp;summary=yes#jcite">21 U.S.C. &sect; 823</a>(f)), and other CSA-authorized uses. Under the plaintiffs'
interpretation, their state-sanctioned, doctor-recommended marijuana use is
covered under the supervised use exception. Under the cities'
interpretation, the plaintiffs' state-authorized medical marijuana use is
not covered by any exception because it is not authorized by the CSA or
another provision of federal law. Although <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%20%2012210(d)(1)&amp;summary=yes#jcite">&sect; 12210(d)(1)</a>'s language lacks a
plain meaning and its legislative history is not conclusive, we hold, in
light of the text and legislative history of the ADA, as well as the
relationship between the ADA and the CSA, that the cities' interpretation is
correct.
<span CLASS="page_no" data-cite="684 f 3d 830" data-cite-type="PrimaryFederalReporter" data-cite-pageno="830" data-primary-citation="684 F.3d 825">[*830]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The meaning of <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%20%2012210(d)(1)&amp;summary=yes#jcite">&sect; 12210(d)(1)</a> cannot be discerned from the text alone. Both
interpretations of the provision are somewhat problematic. The cities'
reading of the statute renders the first clause in <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%2012210(d)(1)&amp;summary=yes#jcite">&sect; 12210(d)(1)</a>'s second
sentence superfluous; if Congress had intended that the exception cover only
uses authorized by the CSA and other provisions of federal law, it could
have omitted the "taken under supervision" language altogether. But the
plaintiffs' interpretation also fails to "giv[e] effect to each word" of <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%20%2012210(d)(1)&amp;summary=yes#jcite">&sect;
12210(d)(1)</a>, <i>United States v, Cabaccang</i>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XFI90V?jcsearch=332%20f%203d%20622&amp;summary=yes#jcite">332 F.3d 622</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XFI90V?jcsearch=332%20f%203d%20622&amp;summary=yes#jcite">627</a> (9th Cir.2003)
(en banc), for if Congress had really intended that the language excepting
"other uses authorized by the Controlled Substances Act or other provisions
of Federal law" be entirely independent of the preceding supervised use
language, it could have omitted the word "other," thus excepting "use of a
drug taken under supervision by a licensed health care professional, <i>or</i>
<i>uses</i>authorized by the Controlled Substances Act." Moreover, unless the word
"other" is omitted, the plaintiffs' interpretation renders the statutory
language outright awkward. One would not <i>naturally</i>describe "the use of a
drug taken under supervision by a licensed health care professional, or
<i>other</i>uses authorized by the Controlled Substances Act or other provisions of
Federal law" unless the supervised uses were a <i>subset</i>of the <span CLASS="page_no" data-cite="2012 bl 123718 p 4" data-cite-type="Bloomberg" data-cite-pageno="4" data-primary-citation="">[**4]</span> uses authorized
by the CSA and other provisions of federal law. The plaintiffs' reading thus
results not only in surplusage, but also in semantic dissonance. <i>Cf. Coos</i>
<i>Cnty. Bd. of Cnty. Comm'rs v. Kempthorne</i>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1955RA003?jcsearch=531%20f%203d%20792&amp;summary=yes#jcite">531 F.3d 792</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1955RA003?jcsearch=531%20f%203d%20792&amp;summary=yes#jcite">806</a> (9th Cir.2008)
(declining to adopt the plaintiffs "tortured reading of the statute's plain
text").<a HREF="#fn600" name="fnref_fn600">[fn6]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The cities' interpretation also makes the most sense of the contested
language when it is viewed in context. <i>See United States v. Havelock</i>,
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1GTMS4003?jcsearch=664%20f%203d%201284&amp;summary=yes#jcite">664 F.3d 1284</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1GTMS4003?jcsearch=664%20f%203d%201284&amp;summary=yes#jcite">1289</a> (9th Cir.2012) (en banc) ("Statutory interpretation
focuses on `the language itself, the specific context in which that language
is used, and the broader context of the statute as a whole.'" (quoting
<i>Robinson v. Shell Oil Co.</i>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CCSA?jcsearch=519%20us%20337&amp;summary=yes#jcite">519 U.S. 337</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CCSA?jcsearch=519%20us%20337&amp;summary=yes#jcite">341</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CCSA?jcsearch=117%20supreme%20court%20843&amp;summary=yes#jcite">117 S.Ct. 843</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CCSA?jcsearch=136%20l%20ed%202d%20808&amp;summary=yes#jcite">136 L.Ed.2d 808</a>
(1997))). Here, the context reveals Congress' intent to define "illegal use
of drugs" by reference to federal, rather than state, law. Section
12210(d)(1) mentions the CSA by name twice, and <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%20%2012210(d)(2)&amp;summary=yes#jcite">&sect; 12210(d)(2)</a> provides that
"[t]he term `drug' means a controlled substance, as defined in schedules I
through V of <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1976CA003?jcsearch=21%20U.S.C.%20%20812&amp;summary=yes#jcite">section 202</a> of the Controlled Substances Act."
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%20%2012210(d)(2)&amp;summary=yes#jcite">42 U.S.C. &sect; 12210</a>(d)(2).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We therefore conclude that the cities' interpretation of the statutory
text is the more persuasive, though we agree with the dissent that the text
is ultimately inconclusive. We therefore look to legislative history,
including related congressional activity.<span CLASS="page_no" data-cite="684 f 3d 831" data-cite-type="PrimaryFederalReporter" data-cite-pageno="831" data-primary-citation="684 F.3d 825">[*831]</span> <a HREF="#fn700" name="fnref_fn700">[fn7]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">

</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The legislative history of <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%20%2012210(d)&amp;summary=yes#jcite">&sect; 12210(d)</a>, like its text, is indeterminate. It
is true, as the plaintiffs point out, that Congress rejected an early draft
of the "taken under supervision" exception in favor of a broader version.
<i>Compare</i><a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/1?citation=S.%20933,%20101st%20Cong&amp;summary=yes#jcite">S. 933, 101st Cong</a>. <cite>&sect; 512(b)</cite> (as passed by the Senate, Sept. 7, 1989)
("The term `illegal drugs' does not mean the use of a controlled substance
<i>pursuant to a valid prescription</i>or other uses authorized by the Controlled
Substances Act or other provisions of Federal law." (emphasis added)),
<i>with</i>H.R. 2273, 101st Cong. <cite>&sect; 510(d)(1)</cite> (as passed by the House, May 22,
1990) ("Such term does not include the use of a drug <i>taken under supervision</i>
<i>by a licensed health care professional</i>, or other uses authorized by the
Controlled Substances Act or other provisions of Federal law." (emphasis
added)), <i>and</i>H.R. Conf. Rep. No. 101-596, at 2 (1990), <i>reprinted in</i>1990
U.S.C.C.A.N. 565, 566 (explaining that the House version of the illegal drug
exclusion was chosen over the Senate version). We are not persuaded,
however, that this history compels the plaintiffs' interpretation of <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%20%2012210(d)(1)&amp;summary=yes#jcite">&sect;
12210(d)(1)</a>. Although the expansion of the supervised use exception suggests
Congress wanted to cover more than just CSA-authorized
<i>prescription-based</i>use, it does not demonstrate that the exception was meant
to extend beyond the set of uses authorized by the CSA and other provisions
of federal law. The CSA does authorize some professionally supervised drug
use that is not prescription-based, <i>see</i><a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1976CM003?jcsearch=21%20U.S.C.%20%C2%A7%20823(f)&amp;summary=yes#jcite">21 U.S.C. &sect; 823(f)</a> (providing for
practitioner dispensation of controlled substances in connection with
approved research studies), and Congress could have intended simply to
expand the supervised use exception to encompass all such uses.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  One House Committee Report does include a brief passage that arguably
supports the notion that <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%2012210(d)(1)&amp;summary=yes#jcite">&sect; 12210(d)(1)</a>'s supervised use language and its
authorized use language are independent. <i>See</i>H.R.Rep. No. 101-185, pt. 3, at
75 (1990), 1990 U.S.C.C.A.N. 445, 498 ("The term `illegal use <span CLASS="page_no" data-cite="2012 bl 123718 p 5" data-cite-type="Bloomberg" data-cite-pageno="5" data-primary-citation="">[**5]</span> of drugs' does
not include the use of controlled substances, including experimental drugs,
taken under the supervision of a licensed health care professional. It
<i>also</i>does not include uses authorized by the Controlled Substances Act or
other provisions of federal law." (emphasis added)). This discussion is of
limited persuasive value, however, because it may rest on the unstated
assumption &mdash; quite plausible at the time &mdash; that professionally supervised
use of illegal drugs would always be consistent with the CSA. In fact, the
expert mental drug use listed in the House Committee Report as an example of
the sort of use covered by the supervised use exception is itself
CSA-authorized. See <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1976CM003?jcsearch=21%20U.S.C.%20%20823(f)&amp;summary=yes#jcite">21 U.S.C. &sect; 823</a>(f). There is no reason to think that the
1990 Congress that passed the ADA would have anticipated later changes in
state law facilitating professional supervision of drug use that federal law
does not permit. The first such change came six years later, when California
voters passed Proposition 215, now codified as the Compassionate Use Act of
1996. <i>See<span CLASS="page_no" data-cite="684 f 3d 832" data-cite-type="PrimaryFederalReporter" data-cite-pageno="832" data-primary-citation="684 F.3d 825">[*832]</span> </i>

<i>Gonzales v. Raich</i>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X12CN6C003?jcsearch=545%20us%201&amp;summary=yes#jcite">545 U.S. 1</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X12CN6C003?jcsearch=545%20us%201&amp;summary=yes#jcite">5</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X12CN6C003?jcsearch=125%20supreme%20court%202195&amp;summary=yes#jcite">125 S.Ct. 2195</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X12CN6C003?jcsearch=162%20l%20ed%202d%201&amp;summary=yes#jcite">162 L.Ed.2d 1</a> (2005).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Although it is true, as the dissent points out, that use of marijuana for
medical purposes "was not unthinkable" in 1990, before, during and after
adoption of the ADA there has been a strong and longstanding federal policy
against medical marijuana use outside the limits established by federal law
itself. <i>See </i><a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X12CN6C003?jcsearch=545%20U.S.%201&amp;summary=yes#jcite">id.at 5-6</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X12CN6C003?jcsearch=10-14&amp;summary=yes#jcite">10-14</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X12CN6C003?jcsearch=125%20supreme%20court%202195&amp;summary=yes#jcite">125 S.Ct. 2195</a> (contrasting California's
historical tolerance for medical marijuana with comprehensive federal limits
on marijuana possession imposed by Congress in 1970). In 1970, despite
marijuana's known historical use for medical purposes, Congress listed
marijuana as a Schedule I drug, designating it as a substance having "a high
potential for abuse," "no currently accepted medical use in treatment in the
United States" and "a lack of accepted safety [standards] for use . . .
under medical supervision." Comprehensive Drug Abuse Prevention and Control
Act of 1970, Pub.L. No. <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/1?citation=USACTS%2091-513&amp;summary=yes#jcite">91-513</a>, tit. II, <cite>&sect; 202(b)(1)</cite>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/1?citation=84%20stat%201236&amp;summary=yes#jcite">84 Stat. 1236</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/1?citation=84%20stat%201236&amp;summary=yes#jcite">1247</a>
(codified at <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1976CA003?jcsearch=21%20U.S.C.%20%20812(b)(1)&amp;summary=yes#jcite">21 U.S.C. &sect; 812</a>(b)(1)). In 1989, the Administrator of the Drug
Enforcement Agency (DEA) rejected an administrative law judge's
recommendation that marijuana be relisted from Schedule I to Schedule II
because of its therapeutic advantages. The Administrator said that
"marijuana has not been demonstrated as suitable for use as a medicine."
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/1?citation=54%20federal%20register%2053767&amp;summary=yes#jcite">54 Fed.Reg. 53,767</a>, 53,768 (Dec. 29, 1989). The DEA once again rejected
rescheduling in 1992, reaffirming the absence of accepted medical use of
marijuana. <i>See</i>57 Fed.Reg. 10,499 (Mar. 26, 1992). It did so again in 2001.
<i>See</i>66 Fed.Reg. 20,038 (Apr. 18, 2001). In 1992, the Federal Drug
Administration (FDA) <i>closed</i>the Investigational New Drug (IND) Compassionate
Access Program, which had begun in 1978 and had allowed a few dozen patients
whose serious medical conditions could be relieved only by marijuana to
apply for and receive marijuana from the federal government. <i>See Conant v.</i>
<i>Walters</i>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XE7FCA?jcsearch=309%20f%203d%20629&amp;summary=yes#jcite">309 F.3d 629</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XE7FCA?jcsearch=309%20f%203d%20629&amp;summary=yes#jcite">648</a> (9th Cir.2002); Mark Eddy, Cong. Research Serv.,
RL 33211, Medical Marijuana: Review and Analysis of Federal and State
Policies 8 (2010). In 1998, Congress passed the Omnibus Consolidated and
Emergency Supplemental Appropriations Act for 1999, Pub.L. No. <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/1?citation=USACTS%20105-277&amp;summary=yes#jcite">105-277</a>,
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/1?citation=112%20stat%202681&amp;summary=yes#jcite">112 Stat. 2681</a> (1998). Under the <span CLASS="page_no" data-cite="2012 bl 123718 p 6" data-cite-type="Bloomberg" data-cite-pageno="6" data-primary-citation="">[**6]</span> heading "Not Legalizing Marijuana for
Medicinal Use," this provision stated in part, "Congress continues to
support the existing Federal legal process for determining the safety and
efficacy of drugs and opposes efforts to circumvent this process by
legalizing marijuana, and other Schedule I drugs, for medicinal use without
valid scientific evidence and the approval of the Food and Drug
Administration." <i><cite>Id</cite>.</i>Every year between 1998 and 2009, Congress
<i>blocked</i>implementation of a voter-approved initiative allowing for the
medical use of marijuana in the District of Columbia. <i>See, e.g.</i>,
Consolidated Appropriations Act, 2000, Pub.L. No. <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/1?citation=USACTS%20106-113&amp;summary=yes#jcite">106-113</a>, <cite>&sect; 167</cite>,
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/1?citation=113%20stat%201501&amp;summary=yes#jcite">113 Stat. 1501</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/1?citation=113%20stat%201501&amp;summary=yes#jcite">1530</a> (1999). Between 2003 and 2007, the House annually, and
by large margins, <i>rejected</i>legislation that would have prevented the Justice
Department from using appropriated funds to interfere with implementation of
medical marijuana laws in the states that approved such use. <i>See</i>Eddy, <i><cite>supra</cite></i>,
at 4-5.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Under the plaintiffs' view, the ADA worked a substantial departure from
this accepted federal policy by extending federal protections to federally
prohibited, but state-authorized, medical use of marijuana. That would have
been an extraordinary departure from policy, and one that we would have
expected Congress to take <i>explicitly. Cf. CNA Fin. Corp. v. Donovan</i>,
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XAFHC2?jcsearch=830%20f%202d%201132&amp;summary=yes#jcite">830 F.2d 1132</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XAFHC2?jcsearch=830%20f%202d%201132&amp;summary=yes#jcite">1148</a> (D.C.Cir.1987) (noting that the Supreme Court has
"insisted on
<span CLASS="page_no" data-cite="684 f 3d 833" data-cite-type="PrimaryFederalReporter" data-cite-pageno="833" data-primary-citation="684 F.3d 825">[*833]</span> 
some clear evidence of congressional intent to work `a substantial change in
accepted practice' through [a statutory] revision"). It is unlikely that
Congress would have wished to legitimize state-authorized, federally
proscribed medical marijuana use without debate, in an ambiguously worded
ADA provision.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Moreover, contrary to the dissent's suggestion, Congress did not need to
include medical marijuana use under the ADA's supervised use exception to
ensure that the federal medical marijuana program &mdash; the IND Compassionate
Access Program &mdash; would be covered by <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%20%2012210(d)(1)&amp;summary=yes#jcite">&sect; 12210(d)(1)</a>. The federal program was
presumably authorized by the CSA's limited experimental research provisions,
<i>see</i><a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1976CM003?jcsearch=21%20U.S.C.%20%C2%A7%20823(f)&amp;summary=yes#jcite">21 U.S.C. &sect; 823(f)</a>, and was thus already covered by the portion of <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%20%2012210(d)(1)&amp;summary=yes#jcite">&sect;
12210(d)(1)</a> that excepts CSA-authorized uses. The same is true of the
"experimental treatment" programs referenced in the Justice Department
memorandum that the dissent cites. We do not quarrel with the dissent's
observation that Congress intended the supervised medical use exception to
apply to experimental use of controlled substances, including, perhaps,
experimental use of marijuana. These experimental uses, however, are
<i>authorized by federal law</i>, and subject to a comprehensive federal regulatory
regime. We find nothing in the legislative history to suggest that Congress
intended to extend ADA protection to state-authorized, but federally
prohibited, uses of marijuana falling outside this regulatory framework.
There is not one word in the statute or in the legislative history
suggesting that Congress sought to exclude from the definition of illegal
drug use the use of a controlled substance that was lawful under state law
but unlawful and unauthorized under <span CLASS="page_no" data-cite="2012 bl 123718 p 7" data-cite-type="Bloomberg" data-cite-pageno="7" data-primary-citation="">[**7]</span> federal law.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The cities' interpretation not only makes the best sense of the statute's
text and the historical context of its passage, but also is the only
interpretation that fully harmonizes the ADA and the CSA. <i>See In re Transcon</i>
<i>Lines</i>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X30FBC?jcsearch=58%20f%203d%201432&amp;summary=yes#jcite">58 F.3d 1432</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X30FBC?jcsearch=58%20f%203d%201432&amp;summary=yes#jcite">1440</a> (9th Cir.1995) ("[W]e must, whenever possible,
attempt to reconcile potential conflicts in statutory provisions."). To
conclude that use of marijuana for medical purposes is <i>not</i>an illegal use of
drugs under the ADA would undermine the CSA's clear statement that marijuana
is an unlawful controlled substance that has "no currently accepted medical
use in treatment in the United States." <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1976CA003?jcsearch=21%20U.S.C.%20%20812(b)(1)(B)&amp;summary=yes#jcite">21 U.S.C. &sect; 812</a>(b)(1)(B). As noted,
Congress reaffirmed this principle in a 1998 appropriations act, <i>see</i>Pub.L.
No. 105-277, div. F., <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/1?citation=112%20stat%202681&amp;summary=yes#jcite">112 Stat. 2681</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/1?citation=112%20stat%202681&amp;summary=yes#jcite">2681-760</a> (1998) ("It is the sense of
Congress that . . . marijuana . . . [has] not been approved . . . to treat
any disease or condition."), and the government has reiterated it in a
number of decisions and advisory memoranda, as well as in its amicus brief
in this appeal. <i>See</i>Brief for the United States as <i>Amicus Curiae; see</i>
<i>also</i>Memorandum from Deputy Att'y Gen. David W. Ogden to Selected U.S.
Att'ys, at 1 (Oct. 19, 2009) [hereinafter Ogden Memo] ("Congress has
determined that marijuana is a dangerous drug."); Memorandum from Deputy
Att'y Gen. James M. Cole to U.S. Att'ys, at 1 (June 29, 2011) (same);
Memorandum from Helen R. Kanovsky, Dep't of Hous. &amp; Urban Dev., to John
Trasvina, Assistant Sec'y for Fair Hous. &amp; Equal Opportunity, et al., at 2
(Jan. 20, 2011) [hereinafter Kanovsky Memo] (stating that marijuana "may not
be legally prescribed by a physician for any reason").<span CLASS="page_no" data-cite="684 f 3d 834" data-cite-type="PrimaryFederalReporter" data-cite-pageno="834" data-primary-citation="684 F.3d 825">[*834]</span> <a HREF="#fn800" name="fnref_fn800">[fn8]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">

</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Accordingly, in light of the text, the legislative history, including
related congressional activity, and the relationship between the ADA and the
CSA, we agree with both district courts that have considered the question,
as well as the Department of Housing and Urban Development and the United
States as amicus curiae, in concluding that doctor-supervised marijuana use
is an illegal use of drugs not covered by the ADA's supervised use
exception. <i>See James v. City of Costa Mesa</i>, <cite>No. SACV 10-0402 AG (MLGx)</cite>,
<cite>2010 WL 1848157</cite>, at *4 (C.D.Cal. Apr. 30, 2010); <i>Barber v. Gonzales</i>, <cite>No.
CV-05-0173-EFS</cite>, [<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XAA9E8N?jcsearch=2005%20BL%2077090&amp;summary=yes#jcite">2005 BL 77090</a>], 2005 WL 1607189, at *1 (E.D.Wash. July 1, 2005); Kanovsky
Memo at 5 ("Under . . . the ADA, whether a given drug or usage is `illegal'
is determined exclusively by reference to the CSA. . . . While . . . the ADA
contain[s] language providing a physician-supervision exemption to the
`current illegal drug user' exclusionary provisions, this exemption does not
apply to medical marijuana users.").<a HREF="#fn900" name="fnref_fn900">[fn9]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  A contrary interpretation of the exception for "use of a drug taken under
supervision by a licensed health care professional" would allow a doctor to
recommend the use of <i>any</i>controlled substance &mdash; including cocaine or heroin &mdash;
and thereby enable the drug user to avoid the ADA's illegal drug exclusion.
Congress could not have intended to create such a capacious loophole,
especially through such an ambiguous provision. <i>Cf. Ross v. Ragingwire</i>
<i>Telecomms., Inc.</i>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X18EKT4003?jcsearch=42%20california%204th%20920&amp;summary=yes#jcite">42 Cal.4th 920</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X18EKT4003?jcsearch=70%20california%20reporter%203d%20382&amp;summary=yes#jcite">70 Cal. Rptr.3d 382</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X18EKT4003?jcsearch=174%20pacific%203d%20200&amp;summary=yes#jcite">174 P.3d 200</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X18EKT4003?jcsearch=207&amp;summary=yes#jcite">207</a>
(2008) (observing, in interpreting California's employment discrimination
law, that "given the controversy that would inevitably have attended a
legislative proposal to require employers to accommodate marijuana <span CLASS="page_no" data-cite="2012 bl 123718 p 8" data-cite-type="Bloomberg" data-cite-pageno="8" data-primary-citation="">[**8]</span> use, we
do not believe that [the relevant statute] can reasonably be understood as
adopting such a requirement silently and without debate").<a HREF="#fn1000" name="fnref_fn1000">[fn10]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We recognize that the federal government's views on the wisdom of
restricting medical marijuana use may be evolving. <i>See</i>Ogden Memo at 1-2
(advising against using federal resources to investigate and prosecute
"individuals whose actions are in clear and unambiguous compliance with
existing state laws providing for the medical use of marijuana"). But for
now Congress has determined that, for purposes of federal law, marijuana is
unacceptable for medical use. See <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1976CA003?jcsearch=21%20U.S.C.%20%20812(b)(1)(B)&amp;summary=yes#jcite">21 U.S.C. &sect; 812</a>(b)(1)(B). We decline to
construe an ambiguous provision in the ADA as a tacit qualifier of the
<span CLASS="page_no" data-cite="684 f 3d 835" data-cite-type="PrimaryFederalReporter" data-cite-pageno="835" data-primary-citation="684 F.3d 825">[*835]</span> 
clear position expressed in the CSA. Accordingly, we hold that federally
prohibited medical marijuana use does not fall within <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%2012210(d)(1)&amp;summary=yes#jcite">&sect; 12210(d)(1)</a>'s
supervised use exception.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>II.</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The plaintiffs contend that even if their marijuana use does not fall
within the <cite>&sect; 12210(d)(1)</cite> exception for "use of a drug taken under
supervision by a licensed health care professional," it nonetheless comes
within the separate exception for drug use "authorized by . . . other
provisions of Federal law," by virtue of recent congressional action
allowing the implementation of a Washington, D.C. medical marijuana
initiative. We reject this argument.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  D.C.'s Initiative 59 suspended local criminal penalties for seriously ill
individuals who use medical marijuana with a doctor's recommendation. See
D.C. Act 13-138, &sect; 2 &amp; 3 (Sept. 20, 1999) (providing that such individuals
do not violate the District of Columbia Uniform Controlled Substances Act).
Although D.C. voters passed this initiative in 1998, Congress blocked its
implementation through an appropriations provision known as the Barr
Amendment, as noted earlier. See Consolidated Appropriations Act of 2000,
Pub.L. No. <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/1?citation=USACTS%20106-113&amp;summary=yes#jcite">106-113</a>, <cite>&sect; 167(b)</cite>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/1?citation=113%20stat%201501&amp;summary=yes#jcite">113 Stat. 1501</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/1?citation=113%20stat%201501&amp;summary=yes#jcite">1530</a> (1999) ("Initiative 59 .
. . shall not take effect."); Comment, <i>Seeking a Second Opinion: How to Cure</i>
<i>Maryland's Medical Marijuana Law</i>, 40 U. Bait. L.Rev. 139, 149 n. 61 (2010)
(describing the history of the Barr Amendment). Congress reenacted the Barr
Amendment every year thereafter until 2009, when it passed an appropriations
bill without the Barr Amendment language. <i>See</i>Consolidated Appropriations Act
of 2010, Pub.L. No. <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/1?citation=USACTS%20111-117&amp;summary=yes#jcite">111-117</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/1?citation=123%20stat%20334&amp;summary=yes#jcite">123 Stat. 334</a> (2009). Soon afterward, the D.C.
Council approved implementation of Initiative 59, <i>see</i>D.C. Act 18-210 (June
4, 2010), and Congress did not pass any joint resolution of disapproval,
thus allowing the initiative to take effect. <i>See Marijuana Policy Project v.</i>
<i>United States</i>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X6B9GU?jcsearch=304%20f%203d%2082&amp;summary=yes#jcite">304 F.3d 82</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X6B9GU?jcsearch=304%20f%203d%2082&amp;summary=yes#jcite">83</a> (D.C.Cir.2002) ("D.C. Council enactments
become law only if Congress declines to pass a joint resolution of
disapproval within thirty days.").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The plaintiffs argue that these congressional actions amount to "other
provisions of Federal law" that authorize their medical marijuana use under
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%20%2012210(d)(1)&amp;summary=yes#jcite">&sect; 12210(d)(1)</a>. We disagree. By allowing Initiative 59 to take effect,
Congress merely declined to stand in the way of D.C.'s efforts to suspend
<i>local</i>penalties on medical marijuana use. It did not affirmatively authorize
medical marijuana use for purposes <i>of federal</i>law, which continues
unambiguously to prohibit such <span CLASS="page_no" data-cite="2012 bl 123718 p 9" data-cite-type="Bloomberg" data-cite-pageno="9" data-primary-citation="">[**9]</span> use.<a HREF="#fn1100" name="fnref_fn1100">[fn11]</a><i>See</i>Webster's Third New
International Dictionary 147 (2002) (" <i>Authorize</i>indicates endowing formally
with a power or right to act.").
<span CLASS="page_no" data-cite="684 f 3d 836" data-cite-type="PrimaryFederalReporter" data-cite-pageno="836" data-primary-citation="684 F.3d 825">[*836]</span> 
Moreover, even if Congress' actions somehow implicitly authorized medical
marijuana use <i>in the District of Columbia</i>, Congress in no way authorized the
plaintiffs' medical marijuana use in <i>California.</i>Congress' actions therefore
did not bring the plaintiffs' marijuana use within the <cite>&sect; 12210(d)(1)</cite>
exception.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We also do not agree with the plaintiffs that "[e]qual protection . . .
mandates" a different conclusion. Congress' decision not to block
implementation of Initiative 59 did not result in the unequal treatment of
District of Columbia and California residents. On the contrary, Congress'
actions allow these jurisdictions to determine for themselves whether to
suspend their <i>local</i>prohibitions on the use and distribution of marijuana for
medical purposes. Local decriminalization notwithstanding, the unambiguous
<i>federal</i>prohibitions on medical marijuana use set forth in the CSA continue
to apply equally in both jurisdictions, as does the ADA's illegal drug
exclusion. There is no unequal treatment, and thus no equal protection
violation. <i>See Boos v. Barry</i>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CBJD?jcsearch=485%20us%20312&amp;summary=yes#jcite">485 U.S. 312</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CBJD?jcsearch=485%20us%20312&amp;summary=yes#jcite">333</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CBJD?jcsearch=108%20supreme%20court%201157&amp;summary=yes#jcite">108 S.Ct. 1157</a>,
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CBJD?jcsearch=99%20l%20ed%202d%20333&amp;summary=yes#jcite">99 L.Ed.2d 333</a> (1988) (remarking that a statute could only run afoul of the
Equal Protection Clause if construed to generate unequal treatment).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We therefore reject the plaintiffs' argument that their use of medical
marijuana was authorized by Congress when it allowed implementation of
D.C.'s Initiative 59.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  CONCLUSION
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We hold that doctor-recommended marijuana use permitted by state law, but
prohibited by federal law, is an illegal use of drugs for purposes of the
ADA, and that the plaintiffs' federally proscribed medical marijuana use
therefore brings them within the ADA's illegal drug exclusion. This
conclusion is not altered by recent congressional actions allowing the
implementation of the District of Columbia's local medical marijuana
initiative. The district court properly concluded that the plaintiffs' ADA
challenge to the cities' efforts to close their medical marijuana
collectives is unlikely to succeed on the merits. The district court
therefore did not abuse its discretion by denying preliminary injunctive
relief. <i>See Farris v. Seabrook</i>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1HEQIQ003?jcsearch=677%20f%203d%20858&amp;summary=yes#jcite">677 F.3d 858</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1HEQIQ003?jcsearch=677%20f%203d%20858&amp;summary=yes#jcite">863-65</a> (9th Cir.2012)
(describing the legal standard applicable to preliminary injunctive relief
and the standard of review on appeal).<a HREF="#fn1200" name="fnref_fn1200">[fn12]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The parties shall bear their own costs on appeal.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>AFFIRMED.</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn100" name="fn100">[fn1]</a></span> We assume, as the parties do, that Costa Mesa's efforts to close
medical marijuana "dispensaries" include the marijuana dispensing facilities
that serve the plaintiffs, which the complaint terms "collectives." Compl. &para;
6, 10-11.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn200" name="fn200">[fn2]</a></span> The complaint alleged that "[e]ach of the plaintiffs is a qualified
person with a disability as defined in the ADA." Compl.&para; 4. It further
alleged that each of the defendant cities is covered by Title II, under
which public entities "must not intentionally or on a disparate impact basis
discriminate against the disabled individual's meaningful access to public
services." <i>Id.</i>&para; 20. The complaint sought an order requiring the cities to
"cease and desist any further action to remove existing marijuana
collectives organized under the laws of California," as well as to establish
regulations "that will accommodate the needs of qualified persons under the
ADA so as to be able to legally access marijuana under California law."
<i></i><cite>Id.at 5-6</cite>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn300" name="fn300">[fn3]</a></span> We do <i>not</i>hold, as the dissent states, that "medical marijuana users
are not protected by the ADA in any circumstance." We hold instead that the
ADA does not protect medical marijuana users who claim to face
discrimination <i>on the basis of</i>their marijuana use. See <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%20%2012210(a)&amp;summary=yes#jcite">42 U.S.C. &sect; 12210</a>(a)
(the illegal drag use exclusion applies only "when the covered entity acts
on the basis of such use"). As the Equal Employment Opportunity Commission
has explained,
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
A person who alleges disability based on one of the excluded conditions
[such as current use of illegal drugs or compulsive gambling, <i>see</i><a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC8003?jcsearch=42%20U.S.C.%20%C2%A7%2012211(b)(2)&amp;summary=yes#jcite">42 U.S.C. &sect;
12211(b)(2)</a>,] is not an individual with a disability under the ADA. Note,
however, that a person who has one of these conditions is an individual with
a disability if (s)he has another condition that rises to the level of a
disability. See House Education and Labor Report at 142. Thus, a compulsive
gambler who has a heart impairment that substantially limits his/her major
life activities is an individual with a disability. Although compulsive
gambling is not a disability, the individual's heart impairment is a
disability.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
U.S. Equal Emp't Opportunity Comm'n, <cite>Section 902</cite> Definition of the Term
Disability, at <cite>&sect; 902.6</cite> (last modified No. 21, 2009), <i>available</i>
<i>at</i>http://www.eeoc.gov/policy/docs/902 cm.html (last visited Apr. 27, 2012).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn400" name="fn400">[fn4]</a></span> Under Title II of the ADA, "no qualified individual with a disability
shall, by reason of such disability, be excluded from participation in or be
denied the benefits of the services, programs, or activities of a public
entity or be subjected to discrimination by any such entity."
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJK9K003?jcsearch=42%20usc%2012132&amp;summary=yes#jcite">42 U.S.C. &sect; 12132</a>. A "public entity" includes "any State or local
government," <i><cite>id</cite>.</i><a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJK9I003?jcsearch=42%20U.S.C.%20%2012131(1)(A)&amp;summary=yes#jcite">&sect; 12131(1)(A)</a>, and there is no dispute that the defendant
cities are public entities for purposes of Title II.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn500" name="fn500">[fn5]</a></span> The cities do not dispute that they have acted "on the basis of" the
plaintiffs' marijuana use by restricting the operation of the medical
marijuana collectives on which the plaintiffs rely.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn600" name="fn600">[fn6]</a></span> Unlike our dissenting colleague, we do not place great significance on
the use of a comma to separate supervised uses from other uses authorized by
the CSA and other federal laws. We very much doubt Congress would have
relied on a single comma to acknowledge the legitimacy of a highly
controversial medical practice. <i>Cf. Crandon v. United States</i>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CBS6?jcsearch=494%20us%20152&amp;summary=yes#jcite">494 U.S. 152</a>,
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CBS6?jcsearch=494%20us%20152&amp;summary=yes#jcite">169</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CBS6?jcsearch=110%20supreme%20court%20997&amp;summary=yes#jcite">110 S.Ct. 997</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CBS6?jcsearch=108%20l%20ed%202d%20132&amp;summary=yes#jcite">108 L.Ed.2d 132</a> (1990) (Scalia, J., concurring)
(remarking, in discounting the significance of a misplaced comma, that "the
evidence . . . should be fairly clear before one concludes that Congress has
slipped in an additional requirement in such an unusual fashion").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn700" name="fn700">[fn7]</a></span> "`If the statutory language is unambiguous and the statutory scheme is
coherent and consistent,' judicial inquiry must cease." <i>Miranda v.</i>
<i>Anchondo.</i><a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1H3NIC003?jcsearch=684%20F.3d%20844&amp;summary=yes#jcite">684 F.3d 844</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1H3NIC003?jcsearch=849&amp;summary=yes#jcite">849</a> (9th Cir.2012) (quoting <i>In re Ferrell</i>,
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X19FECK003?jcsearch=539%20f%203d%201186&amp;summary=yes#jcite">539 F.3d 1186</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X19FECK003?jcsearch=539%20f%203d%201186&amp;summary=yes#jcite">1190</a> n. 10 (9th Cir.2008)). If the statute is ambiguous,
however, "we may use canons of construction, legislative history, and the
statute's overall purpose to illuminate Congress's intent." <i>Probert v.</i>
<i>Family Centered Servs. of Alaska, Inc.</i>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1FK7O4003?jcsearch=651%20f%203d%201007&amp;summary=yes#jcite">651 F.3d 1007</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1FK7O4003?jcsearch=651%20f%203d%201007&amp;summary=yes#jcite">1011</a> (9th Cir.2011)
(quoting <i>Jleto v. Clock, Inc.</i>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1B3644003?jcsearch=565%20f%203d%201126&amp;summary=yes#jcite">565 F.3d 1126</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1B3644003?jcsearch=565%20f%203d%201126&amp;summary=yes#jcite">1133</a> (9th Cir.2009)) (internal
quotation marks omitted). "We may also look to other related statutes
because `statutes dealing with similar subjects should be interpreted
harmoniously.'" <i>Tides v. Boeing Co.</i>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1FDBPU003?jcsearch=644%20f%203d%20809&amp;summary=yes#jcite">644 F.3d 809</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1FDBPU003?jcsearch=644%20f%203d%20809&amp;summary=yes#jcite">814</a> (9th Cir.2011)
(quoting <i>United Stales v. Nader</i>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X19GPH2003?jcsearch=542%20f%203d%20713&amp;summary=yes#jcite">542 F.3d 713</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X19GPH2003?jcsearch=542%20f%203d%20713&amp;summary=yes#jcite">717</a> (9th Cir.2008)); <i>see also</i>
<i>Tidewater Oil Co. v. United States</i>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5C88E?jcsearch=409%20us%20151&amp;summary=yes#jcite">409 U.S. 151</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5C88E?jcsearch=409%20us%20151&amp;summary=yes#jcite">157-58</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5C88E?jcsearch=93%20supreme%20court%20408&amp;summary=yes#jcite">93 S.Ct. 408</a>,
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5C88E?jcsearch=34%20l%20ed%202d%20375&amp;summary=yes#jcite">34 L.Ed.2d 375</a> (1972) (stating that "it is essential that we place the words
of a statute in their proper context by resort to the legislative history,"
including related congressional activity addressing the same subject
matter).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn800" name="fn800">[fn8]</a></span> Before oral argument, we invited the view of the United States as
amicus curiae. The government accepted our invitation and filed an amicus
brief supporting the cities' interpretation:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
The proper interpretation of the term "illegal use of drugs," as defined in
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%2012210(d)&amp;summary=yes#jcite">42 U.S.C. [&sect;] 12210(d)</a>, includes the use of marijuana taken under doctor
supervision, unless that use is authorized by the CSA or another federal
law, which is not the case here. Federal law makes clear that medical
marijuana use does not receive special protection under the ADA.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
Brief for the United States as <i>Amicus Curiae</i>at 10.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn900" name="fn900">[fn9]</a></span> We do not, as the dissent suggests, resolve the statutory ambiguity
based on an imagined inconsistency between the express terms of the ADA and
"general considerations of supposed public interests" derived from the CSA.
<i>United Paperworkers Int'l Union v. Misco</i>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CBH8?jcsearch=484%20us%2029&amp;summary=yes#jcite">484 U.S. 29</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CBH8?jcsearch=484%20us%2029&amp;summary=yes#jcite">43</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CBH8?jcsearch=108%20supreme%20court%20364&amp;summary=yes#jcite">108 S.Ct. 364</a>,
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CBH8?jcsearch=98%20l%20ed%202d%20286&amp;summary=yes#jcite">98 L.Ed.2d 286</a> (1987) (quoting <i>W.R. Grace &amp; Co. v. Rubber Workers</i>,
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CAH8?jcsearch=461%20us%20757&amp;summary=yes#jcite">461 U.S. 757</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CAH8?jcsearch=461%20us%20757&amp;summary=yes#jcite">766</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CAH8?jcsearch=103%20supreme%20court%202177&amp;summary=yes#jcite">103 S.Ct. 2177</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CAH8?jcsearch=76%20l%20ed%202d%20298&amp;summary=yes#jcite">76 L.Ed.2d 298</a> (1983)) (internal
quotation marks omitted). The CSA directly addresses whether medical
marijuana use constitutes illegal use of drugs, and clearly states that such
use is unlawful.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1000" name="fn1000">[fn10]</a></span> The dissent dismisses this problem, arguing that state licensing
requirements are sufficient to limit the reach of the supervised use
exception. State licensing requirements do not eliminate the potential
absurdity, however. A doctor who recommends the use of an illegal drug might
still succeed in preserving ADA protection for the drug user, even if the
doctor's behavior might ultimately result in discipline before the state
licensing authority.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1100" name="fn1100">[fn11]</a></span> It is true, of course, that, because the District of Columbia is not
sovereign, the D.C. Council's legislative power is derived from that of
Congress. <i>See</i><a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/1?citation=USCONST%20ART%20I,%20SC%208&amp;summary=yes#jcite">U.S. Const. art. 1, &sect; 8, cl. 17</a> ("Congress shall have Power . .
. [t]o exercise exclusive Legislation in all Cases whatsoever, over . . .
the Seat of the Government of the United States."); <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XPA52G003?jcsearch=D.C.%20Code%20%201-203.02&amp;summary=yes#jcite">D.C.Code Ann. &sect;
1-203.02</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XP9INK003?jcsearch=D.C.%20Code%20%201-204.04&amp;summary=yes#jcite">1-204.04</a> (delegating some of Congress' legislative power to the
District and enumerating the powers of the D.C. Council). But "[u]nlike most
congressional enactments, the [D.C] Code is a comprehensive set of laws
equivalent to those enacted by state and local governments." <i>Key v. Doyle</i>,
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5C9FU?jcsearch=434%20us%2059&amp;summary=yes#jcite">434 U.S. 59</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5C9FU?jcsearch=434%20us%2059&amp;summary=yes#jcite">68</a> n. 13, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5C9FU?jcsearch=98%20supreme%20court%20280&amp;summary=yes#jcite">98 S.Ct. 280</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5C9FU?jcsearch=54%20l%20ed%202d%20238&amp;summary=yes#jcite">54 L.Ed.2d 238</a> (1977). D.C. Council
enactments are therefore not "federal" laws in the usual sense. <i>See United</i>
<i>Slates v. Weathers</i>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X17A15O003?jcsearch=493%20f%203d%20229&amp;summary=yes#jcite">493 F.3d 229</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X17A15O003?jcsearch=493%20f%203d%20229&amp;summary=yes#jcite">236</a> (D.C.Cir.2007) (distinguishing between
counts charged "under federal law" and "under the D.C. Code"); <i>Foretich v.</i>
<i>United States</i>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X6CVHQ?jcsearch=351%20f%203d%201198&amp;summary=yes#jcite">351 F.3d 1198</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X6CVHQ?jcsearch=351%20f%203d%201198&amp;summary=yes#jcite">1205</a> (D.C.Cir.2003) (referring to "criminal
liability under both D.C. and federal law").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1200" name="fn1200">[fn12]</a></span> Because we conclude that the plaintiffs are not qualified individuals
with a disability protected by the ADA, we do not reach Costa Mesa's
alternative argument that the ADA docs not require accommodation of a
qualified individual's "misconduct." Likewise, because we conclude that the
district court properly denied preliminary injunctive relief, we need not
decide whether the Anti-Injunction Act would prohibit the court from
enjoining Lake Forest from pursuing its state-court public nuisance action.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  BERZON, Circuit Judge, concurring in part and dissenting in part:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The statutory interpretation issue at the core of this case is an
unusually tough one, as the majority opinion recognizes. Looking at the
language of <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%20%2012210(d)(1)&amp;summary=yes#jcite">&sect; 12210(d)(1)</a> alone, I would come out where the majority does &mdash;
concluding that the statute is ambiguous. But unlike the majority, I would
not declare a near-draw. Instead, looking at the words alone, I would
conclude that the plaintiffs have much the better reading, but not by enough
to be comfortable that their interpretation is surely correct. Turning then
to the legislative history, I would again declare the plaintiffs the winner,
<span CLASS="page_no" data-cite="684 f 3d 837" data-cite-type="PrimaryFederalReporter" data-cite-pageno="837" data-primary-citation="684 F.3d 825">[*837]</span> 
this time sufficiently, when <span CLASS="page_no" data-cite="2012 bl 123718 p 10" data-cite-type="Bloomberg" data-cite-pageno="10" data-primary-citation="">[**10]</span> combined with the language considerations, to
adopt their interpretation, absent some very good reason otherwise. And I am
decidedly not convinced that the majority's facile "trump" via the
Controlled Substances Act.("CSA") works, because, among other reasons, the
supposed tension relied upon does not exist.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  I therefore would not decide the case on the broad ground that medical
marijuana users are not protected by the ADA in inclined to agree with the
result the majority reaches on the narrower basis that the particular claim
made here is not cognizable, it is not appropriate at this juncture to reach
that question. I therefore respectfully dissent.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>1. Statutory Text</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  At the heart of this case is <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%20%2012210(d)(1)&amp;summary=yes#jcite">&sect; 12210(d)(1)</a> of the ADA, which defines
"illegal use of drugs" as
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      the use of drugs, the possession or distribution of which is
    unlawful under the Controlled Substances Act. Such term does not
    include the use of a drug taken under supervision by a licensed
    health care professional, or other uses authorized by the Controlled
    Substances Act or other provisions of Federal law.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%20%2012210(d)(1)&amp;summary=yes#jcite">42 U.S.C. &sect; 12210</a>(d)(1). James and the other plaintiffs (collectively,
"James") argue that the first clause of the second sentence carves out their
marijuana use, which is under the supervision of a doctor and in compliance
with California law. The Cities, on the other hand, read the statute as
creating a single exception &mdash; for drug use authorized by the CSA &mdash; and argue
that the first clause should be read as excepting drug use under supervision
of a doctor only when that use complies with the CSA.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Although <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%20%2012210(d)(1)&amp;summary=yes#jcite">&sect; 12210(d)(1)</a> is not entirely clear, James has the better reading
of the statutory language, albeit not to a dispositive degree. In James's
view, the phrases "use of a drug taken under supervision by a licensed
health care professional" and "other uses authorized by the [CSA]" create
<i>two different</i>exceptions, so that the ADA protects use of drugs under
supervision of a doctor even when that use is not authorized by the CSA. If
Congress intended to carve out only drug use authorized by the CSA, after
all, the entire first clause &mdash; "the use of a drug under supervision by a
licensed health care professional" &mdash; would have been unnecessary.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>a. The use of "other"</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Cities argue, and the district court held, that James's reading
renders the word "other" redundant, since Congress could have more clearly
and concisely conveyed the meaning of two distinct exceptions by leaving it
out. Under this view, "other" indicates that the exception contained in the
first clause, for uses supervised by a doctor, is meant to be a subset of
the exception in the second clause, and is included only for clarification
and emphasis. This interpretation would, oddly, prefer a minor redundancy &mdash;
the word "other" &mdash; over a major one &mdash; the entire first phrase of the second
sentence.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Moreover, the word "other" is not necessarily redundant at all. It <i>could</i>be
read to indicate that use under supervision of a doctor is meant to be a
category of uses entirely subsumed by the larger category of uses authorized
by the CSA, but this <span CLASS="page_no" data-cite="2012 bl 123718 p 11" data-cite-type="Bloomberg" data-cite-pageno="11" data-primary-citation="">[**11]</span> is not the only possible interpretation. Put another
way, omitting the word "other" entirely would certainly have compelled the
reading James advances, but its presence does not invalidate her
interpretation. There is, after all, a middle ground between these two
readings: The two exceptions could be entirely separate categories of uses,
or, as the Cities see them, entirely
<span CLASS="page_no" data-cite="684 f 3d 838" data-cite-type="PrimaryFederalReporter" data-cite-pageno="838" data-primary-citation="684 F.3d 825">[*838]</span> 
overlapping, with the former a subset of the latter. But the two clauses
could also be seen as <i>partially</i>overlapping, with the group of uses
supervised by a doctor partially included within the set of uses authorized
by the CSA but also partially independent, encompassing in addition a set of
uses not authorized by the CSA. This reading strikes me as the most
sensible.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Under this interpretation, "other" is not redundant. Instead, it
accurately reflects the overlap. Were the "other" not there, the exception
would have divided the relevant universe into two non-overlapping sets. Yet,
in fact the CSA authorizes some (but not all) uses of "drugs taken under
supervision of a licensed health care professional." The "other" serves to
signal that there is no strict dichotomy between the two phrases, as the
bulk of the CSA-authorized uses are within the broader set covered by the
first phrase.<a HREF="#fn101" name="fnref_fn101">[fn1]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>b. The use of a comma</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  There is also a third clause, "or other provisions of Federal law." The
CSA is clearly a provision of Federal law, meaning that this second "other"
is being used to indicate that "uses authorized by the [CSA]" is a subset of
"provisions of Federal law." The Cities argue that Congress used the first
"other" in the same way, suggesting a kind of three-colored bull's eye, in
which use supervised by a doctor is a subset of use authorized by the CSA,
which in turn is a subset of use authorized by Federal law.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  This argument runs aground on the comma that separates the first and
second clauses, as well as on the grammatical infelicity of the syntax the
Cities' interpretation posits. The disjunctive "or" separating those first
two clauses after a comma suggests categories at least partially distinct,
in contrast to the second use of "or," which is not preceded by a comma. The
Cities' reading requires jumping over the comma, so that the phrase
"authorized by the[CSA] or other provisions of Federal law" modifies "a drug
taken under supervision by a licensed health care professional." But in the
English language, modifiers at the ends of phrases do not usually leapfrog
over commas. <i>See The Chicago Manual of Style</i><cite>&sect; 6.31</cite> (16th ed.2010) ("A
dependent clause that follows a main clause should <i>not</i>be preceded by a comma
if it is restrictive, that is, essential to the meaning of the main
clause."). And here, ignoring the comma and tacking the modifier onto the
phrase before the comma yields an exceedingly awkward &mdash; indeed, incoherent &mdash;
locution: "such term does not include the use of a drug taken under
supervision by a licensed health care professional . . . authorized by the
[CSA]. . . ."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  More sensibly, the comma was added to reinforce the understanding that the
first phrase is complete in itself, while "uses" other than those under
medical <span CLASS="page_no" data-cite="2012 bl 123718 p 12" data-cite-type="Bloomberg" data-cite-pageno="12" data-primary-citation="">[**12]</span> supervision must be authorized by federal law. The comma therefore
indicates that the set of uses described by the first clause is not entirely
subsumed by the second clause, substituting for an implicit "if in the
second clause expressing this lack of total overlap. The sentence thus
excepts (1) all supervised uses and (2) other uses as well, if authorized by
the CSA or other federal law.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  This reading of the statute may not be <i>compelled</i>by the text, which remains
a bit ambiguous. But it is, on balance, considerably
<span CLASS="page_no" data-cite="684 f 3d 839" data-cite-type="PrimaryFederalReporter" data-cite-pageno="839" data-primary-citation="684 F.3d 825">[*839]</span> 
more persuasive as a matter of grammar and syntax than the reading advanced
by the Cities. It minimizes the redundancy problem, accords with the use of
the word "other," avoids an awkward syntax, and accounts for the presence of
the comma before "other uses."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>2. Legislative History</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  James' reading of the statute also accords <i>much</i>better with the overall
thrust of the legislative history. That history, while not without ambiguity
itself, strongly supports James's interpretation.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>a. Evolution of the exception</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  As the majority observes, Congress replaced a draft of the exception that
required that use of drugs be "pursuant to a valid prescription," <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/1?citation=S.%20933,%20101st%20Cong&amp;summary=yes#jcite">S. 933,
101st Cong</a>. <cite>&sect; 512(b)</cite>, with the broader language eventually enacted. The
original language provided that "[t]he term `illegal drugs' does not mean
the use of a controlled substance <i>pursuant to a valid prescription</i>or other
uses authorized by the Controlled Substances Act or other provisions of
Federal law," <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/1?citation=S.%20933,%20101st%20Cong&amp;summary=yes#jcite">S. 933, 101st Cong</a>. <cite>&sect; 512(b)</cite> (as passed by the Senate, Sept.
7, 1989) (emphasis added), while the currently in force revision, adopted by
the House in May of 1990 and ultimately chosen over the Senate version in
conference, H.R.Rep. No. 101-596, at 5 (1990) (Conf.Rep.), <i>reprinted in</i>1990
U.S.C.C.A.N. 565 at 566, reads "[s]uch term does not include the use of a
drug <i>taken under supervision by a licensed health care professional</i>, or
other uses authorized by the Controlled Substances Act or other provisions
of federal law." <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%20%2012210(d)(1)&amp;summary=yes#jcite">42 U.S.C. &sect; 12210</a>(d)(1) (emphasis added).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Critically, the House Committee Report restates the exception, once
amended, in precisely the cumulative manner I have suggested most accords
with the statutory language: "The term `illegal use of drugs' does not
include the use of controlled substances, including experimental drugs,
taken under the supervision of a licensed health care professional. It also
does not include uses authorized by the [CSA] or other provisions of Federal
law." H.R.Rep. No. 101-485, pt. 3, at 75 (1990), 1990. U.S.C.C.A.N. 445 at
498. This summary is in no way ambiguous, and indicates at least that
members of the House familiar with the statutory language understood it in
the manner that, for reasons I have explained, most accords with ordinary
principles of grammar and syntax.<span CLASS="page_no" data-cite="684 f 3d 840" data-cite-type="PrimaryFederalReporter" data-cite-pageno="840" data-primary-citation="684 F.3d 825">[*840]</span> <a HREF="#fn201" name="fnref_fn201">[fn2]</a>

</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>b. Congressional awareness of medical marijuana</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The majority discounts any significance in the way the current language is
described in the relevant Committee report, observing that California voters
did not pass Prop. 215 until 1996 and that there were no state laws in 1990
allowing for professionally supervised use of drugs in a manner inconsistent
with the CSA. Congress would not have carefully drafted <span CLASS="page_no" data-cite="2012 bl 123718 p 13" data-cite-type="Bloomberg" data-cite-pageno="13" data-primary-citation="">[**13]</span> the exception to
include non-CSA authorized medically supervised uses, the majority posits,
as no such uses were legal under state law at the time.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  That explanation for dismissing the best reading of the statute and the
only coherent reading of the Committee's explanation of the statute won't
wash, for several reasons. First, while California in 1996 became the first
of the sixteen states that currently legalize medical marijuana, the history
of medical marijuana goes back much further, so that use for medical
purposes was not unthinkable in 1990. At one time, "almost all States . . .
had exceptions making lawful, under specified conditions, possession of
marihuana by . . . persons for whom the drug had been prescribed or to whom
it had been given by an authorized medical person." <i>Leary v. United States</i>,
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5C7JU?jcsearch=395%20us%206&amp;summary=yes#jcite">395 U.S. 6</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5C7JU?jcsearch=395%20us%206&amp;summary=yes#jcite">17</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5C7JU?jcsearch=89%20supreme%20court%201532&amp;summary=yes#jcite">89 S.Ct. 1532</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5C7JU?jcsearch=23%20l%20ed%202d%2057&amp;summary=yes#jcite">23 L.Ed.2d 57</a> (1969). What's more, the
Federal government itself conducted an experimental medical marijuana
program from 1978 to 1992, and it continues to provide marijuana to the
surviving participants. <i>See Conant v. Walters</i>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XE7FCA?jcsearch=309%20f%203d%20629&amp;summary=yes#jcite">309 F.3d 629</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XE7FCA?jcsearch=309%20f%203d%20629&amp;summary=yes#jcite">648</a> (9th
Cir.2002). The existence of these programs indicates that medical marijuana
was not a concept utterly foreign to Congress before 1996.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Second, a deeper look at the legislative history reveals that James's
interpretation may well reflect the particular problem Congress was
addressing when it enacted <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%20%2012210&amp;summary=yes#jcite">&sect; 12210</a>. Originally, the provision that became <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%20%2012210&amp;summary=yes#jcite">&sect;
12210</a> did not exclude users of illegal drugs from the definition of
protected disabled individuals. During hearings before the Committee on
Labor and Human Resources, Senator Harkin, the sponsor of the ADA, faced
criticism that his bill would prevent employers from firing employees who
were found to be under the influence of drugs while at work and was
therefore inconsistent with the Drug-Free Workplace Act of 1988.<a HREF="#fn301" name="fnref_fn301">[fn3]</a>
<i>Americans with Disabilities Act of 1989: Hearing on S. 938 Before the</i>
<i>S. Comm. on Labor and Human Resources</i>, 101st Cong. 40 (1989).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In response, Senator Harkin pointed out that the provisions of the ADA
were modeled after <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEIOHO003?jcsearch=29%20U.S.C.%20%20794&amp;summary=yes#jcite">Section 504</a> of the Rehabilitation Act, and that his
"intent was to incorporate the policies in <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEIOHO003?jcsearch=29%20U.S.C.%20%20794&amp;summary=yes#jcite">Section 504</a> as interpreted by the
Supreme Court and the Justice Department in a recent memo prepared by the
Attorney General." <i><cite>Id</cite>.</i>That memorandum, which was inserted into the record,
explained that, in the view of the Justice Department, "[a]ny legislation
must make clear that the definition of `handicap' does not include those who
use <i>illegal</i>drugs." <i></i><cite>Id.at 836</cite>. The memorandum went on to warn that
<span CLASS="page_no" data-cite="684 f 3d 841" data-cite-type="PrimaryFederalReporter" data-cite-pageno="841" data-primary-citation="684 F.3d 825">[*841]</span> </p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">

</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      [w]e . . . do not wish to penalize those persons who, in limited
    cases, are using `controlled substances' such as marijuana or
    morphine under the supervision of medical professionals as part of a
    course of treatment, including, for example, experimental treatment
    or to relieve the side-effects of chemotherapy. These persons would
    fall under the same category as those who are users of legal drugs.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<i></i><cite>Id.at 837-38</cite>. During the subsequent debates in the Senate, the amendment
quoted above, which used the term "pursuant to a valid prescription" and
lacked the crucial comma, was introduced by Senator Helms. <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/1?citation=135%20Cong.%20Rec.%20S10775&amp;summary=yes#jcite">135 Cong. Rec.
S10775</a> (Sept. 7, 1989). It was, as already explained, <span CLASS="page_no" data-cite="2012 bl 123718 p 14" data-cite-type="Bloomberg" data-cite-pageno="14" data-primary-citation="">[**14]</span> amended to include
language closer to that used in the Justice Department Memorandum &mdash;
"supervision of medical professionals."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  A memorandum from the Justice Department certainly doesn't provide
irrefutable proof of the correct interpretation of statutory text Congress
had not yet adopted. But it does indicate that the issue of medical
marijuana was at least on the federal government's, and Congress's, radar
and not, as the majority would largely have it, an unforeseen revolution six
years in the future.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Further, as noted, the wording of the exception was altered in the House
from the version that had earlier passed the Senate. The majority focuses on
the substantive change from "pursuant to a valid prescription" to "taken
under supervision by a licensed health care professional," noting that the
CSA authorizes uses not pursuant to a prescription. But, for that very
reason, there was no reason to change the wording of <cite>&sect; 512(b)</cite> of the Senate
bill; "other uses authorized by the [CSA]" were already, generically,
covered. A more likely explanation, consistent with the House Committee
Report, was the determination to define a set of uses covered by the
exception <i>whether or not</i>"authorized by the [CSA]," a change carried out by
the alteration in context, syntax, and punctuation &mdash; including the
<i>addition</i>of the comma, otherwise inexplicable.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The upshot is that the statutory language and history, taken together, fit
much better with James's version of what Congress meant than the Cities'.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>3. Conflict with the CSA</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The majority, however, instead declares a near-draw, and then breaks it by
concluding that the Cities' "is the only interpretation that fully
harmonizes the ADA and the CSA." Maj. Op. at 833. Not only do I disagree
with the notion that both interpretations of the statutory language and
history are equally or almost equally viable, I also cannot buy the notion
that judges may invent the manner in which the ADA and the CSA should be
harmonized. As to users of illegal drugs, the statute directly addresses
that question. One way or another, we must find the answer to that
harmonization by interpreting the statute, not by applying our own notion of
how the two statutes ought to interact.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Moreover, I also cannot agree that James's reading of the exception
creates a conflict between the ADA and the CSA so sharp as to provide useful
guidance, from outside the terms of the ADA itself, as to the appropriate
interaction of the two statutes. Nothing in the CSA addresses the civil
rights of a disabled person using drugs for medical purposes, any more than
anything in the CSA addresses whether such a person can recover in tort.
Conversely, recognizing that individuals using CSA-covered drugs are not
excluded from ADA coverage does not preclude prosecuting them under the CSA.
<span CLASS="page_no" data-cite="684 f 3d 842" data-cite-type="PrimaryFederalReporter" data-cite-pageno="842" data-primary-citation="684 F.3d 825">[*842]</span> </p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">

</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  An analogous line of cases is instructive in this regard: In resolving
conflicts between arbitrators' awards and notions of "public policy" gleaned
from statutes, the Supreme Court has focused on direct and specific
incompatibility, rather' than on general notions concerning the underlying
<span CLASS="page_no" data-cite="2012 bl 123718 p 15" data-cite-type="Bloomberg" data-cite-pageno="15" data-primary-citation="">[**15]</span> purpose of competing directives. <i>United Paperworkers International Union v.</i>
<i>Misco</i>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CBH8?jcsearch=484%20us%2029&amp;summary=yes#jcite">484 U.S. 29</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CBH8?jcsearch=108%20supreme%20court%20364&amp;summary=yes#jcite">108 S.Ct. 364</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CBH8?jcsearch=98%20l%20ed%202d%20286&amp;summary=yes#jcite">98 L.Ed.2d 286</a> (1987), and <i>Eastern</i>
<i>Associated Coal Corporation v. United Mine Workers</i>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X4U3HS?jcsearch=531%20us%2057&amp;summary=yes#jcite">531 U.S. 57</a>,
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X4U3HS?jcsearch=121%20supreme%20court%20462&amp;summary=yes#jcite">121 S.Ct. 462</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X4U3HS?jcsearch=148%20l%20ed%202d%20354&amp;summary=yes#jcite">148 L.Ed.2d 354</a> (2000), reviewed arbitration awards
reinstating employees who had been discharged for marijuana use. The
appropriate inquiry as to the validity of the arbitration awards, the Court
noted, must be into "explicit conflict with other `laws and legal
precedents' rather than an assessment of `general considerations of supposed
public interests.'" <i>Misco</i>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CBH8?jcsearch=484%20us%2029&amp;summary=yes#jcite">484 U.S. at 43</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CBH8?jcsearch=484%20us%2029&amp;summary=yes#jcite">108</a> <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CBH8?jcsearch=S.Ct.%20364&amp;summary=yes#jcite">S.Ct. 364</a>(quoting <i>W.R. Grace</i>
<i>&amp; Co. v. Rubber Workers</i>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CAH8?jcsearch=461%20us%20757&amp;summary=yes#jcite">461 U.S. 757</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CAH8?jcsearch=461%20us%20757&amp;summary=yes#jcite">766</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CAH8?jcsearch=103%20supreme%20court%202177&amp;summary=yes#jcite">103 S.Ct. 2177</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CAH8?jcsearch=76%20l%20ed%202d%20298&amp;summary=yes#jcite">76 L.Ed.2d 298</a>
(1983)). Holding that no public policy against illegal drug use was
sufficiently "explicit, well defined, and dominant," <i>United Mine Workers</i>,
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X4U3HS?jcsearch=531%20us%2057&amp;summary=yes#jcite">531 U.S. at 62</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X4U3HS?jcsearch=121%20supreme%20court%20462&amp;summary=yes#jcite">121 S.Ct. 462</a>, to require that individuals who illegally use
marijuana may not be employed, the Court stressed the idea that "the
question to be answered is not whether [the employee's] drug use itself
violates public policy, but whether the agreement to reinstate him does so."
<i></i><a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X4U3HS?jcsearch=531%20U.S.%2057&amp;summary=yes#jcite">Id.at 62-63</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X4U3HS?jcsearch=121%20supreme%20court%20462&amp;summary=yes#jcite">121 S.Ct. 462</a>; <i>see also Misco</i>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CBH8?jcsearch=484%20us%2029&amp;summary=yes#jcite">484 U.S. at 44</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CBH8?jcsearch=108%20supreme%20court%20364&amp;summary=yes#jcite">108 S.Ct. 364</a>;
<i>Southern Cat. Gas Co. v. Util. Workers Union Local 132</i>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X517IO?jcsearch=265%20f%203d%20787&amp;summary=yes#jcite">265 F.3d 787</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X517IO?jcsearch=265%20f%203d%20787&amp;summary=yes#jcite">794-97</a>
(9th Cir.2001).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Similarly here, there could be no square conflict between the CSA and the
ADA were the ADA interpreted, as I suggest, to specify that a medical
marijuana user could be a qualified person with a disability and so not
entirely excluded from the ADA's protection. The CSA does not make it
illegal, for example, to employ a medical marijuana user or to provide such
a user with schooling, unemployment benefits, or other non drug-related
services. Interpreting the ADA to require, in some circumstances, such
employment or schooling or benefits would not conflict with the CSA.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The California Supreme Court recently proceeded from a similar recognition
as to the limits of the direct conflict concept, albeit to the opposite end.
That Court held that the Compassionate Use Act did <i>not</i>dictate protection of
medical marijuana users under the state's version of the ADA. The state
disability statute, unlike the federal ADA, does not address, one way or the
other, whether medical marijuana users are entitled to the protections of
the statute. <i>Ross v. RagingWire Telecommunications Inc.</i>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X18EKT4003?jcsearch=42%20california%204th%20920&amp;summary=yes#jcite">42 Cal.4th 920</a>,
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X18EKT4003?jcsearch=70%20california%20reporter%203d%20382&amp;summary=yes#jcite">70 Cal.Rptr.3d 382</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X18EKT4003?jcsearch=174%20pacific%203d%20200&amp;summary=yes#jcite">174 P.3d 200</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X18EKT4003?jcsearch=204&amp;summary=yes#jcite">204</a> (2008), held that under those
circumstances, the fact that use of medical marijuana is not a criminal
offense in California does not necessarily speak to its status under an
anti-discrimination law. For the same reason, I suggest, the opposite is
also true: that use of medical marijuana is a criminal offense under the CSA
does not speak to its pertinence as a disqualifying factor with regard to
the civil protections otherwise accorded disabled individuals.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  There is, in other words, no direct conflict between the ADA and the CSA
if the ADA is interpreted as I propose. An imagined conflict or tension
should not be dragged in, like a deus ex machina, to settle a difficult
statutory interpretation problem.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  It is worth observing, in addition, that if there were a direct conflict,
it would be the ADA rather than the CSA that would prevail, as the ADA is
the later-enacted statute. Repeals by implication are disfavored; every
effort must therefore be made to make <span CLASS="page_no" data-cite="2012 bl 123718 p 16" data-cite-type="Bloomberg" data-cite-pageno="16" data-primary-citation="">[**16]</span> both statutes operative
<span CLASS="page_no" data-cite="684 f 3d 843" data-cite-type="PrimaryFederalReporter" data-cite-pageno="843" data-primary-citation="684 F.3d 825">[*843]</span> 
within their realm, rather than declaring a clash. <i>Watt v. Alaska</i>,
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CA35?jcsearch=451%20us%20259&amp;summary=yes#jcite">451 U.S. 259</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CA35?jcsearch=451%20us%20259&amp;summary=yes#jcite">267</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CA35?jcsearch=101%20supreme%20court%201673&amp;summary=yes#jcite">101 S.Ct. 1673</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CA35?jcsearch=68%20l%20ed%202d%2080&amp;summary=yes#jcite">68 L.Ed.2d 80</a> (1981). Avoiding a clash by
having the later statute bow to the earlier one, when the two address
different problems and so can co-exist without difficulty, is not
harmonization, but hegemony through prior enactment.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Nor am I dissuaded by the assertion that my interpretation of the
statutory exception "would allow a doctor to recommend the use of
<i>any</i>controlled substance &mdash; including cocaine or heroin." Maj. Op. at 834. The
ADA does not address the practice of medicine. <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%20%2012210&amp;summary=yes#jcite">Section 12210</a> only excepts
use pursuant to supervision by a "licensed health care professional."
Nothing in California law, or, so far as I am aware, the law of any other
state, permits doctors to encourage the use of heroin; a doctor who does so
is unlikely to remain "licensed" for very long, and so the scenario is
unlikely to occur. In contrast, California, which generally licenses medical
professionals, does not penalize those who recommend medical marijuana, nor
may the federal government do so, in many instances. <i>See Conant</i>,
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XE7FCA?jcsearch=309%20f%203d%20629&amp;summary=yes#jcite">309 F.3d at 639</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  At the same time, I am dubious that the exception upon which James relies
can ultimately carry the day in this case. We are concerned here with the
Cities' effort to exclude medical marijuana dispensaries, not with a policy
that prevents disabled individuals who use medical marijuana from, for
example, attending school or obtaining unemployment benefits. The ADA's
definition of "individual with a disability," excluding those who illegally
"use" drugs, and its attendant definition of "illegal use of drugs," are
both phrased in terms of "use," and do not address those who distribute or
sell drugs.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The definition of "illegal use of drugs" applies equally to the ADA's
employment provisions. See <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJK90003?jcsearch=42%20U.S.C.%20%2012111(6)&amp;summary=yes#jcite">42 U.S.C. &sect; 12111</a>(6). That exception, if read as
I suggest, would preclude employers from refusing to hire otherwise
qualified disabled individuals who use medical marijuana, as long as doing
so did not interfere with their ability to carry out their duties safely.
The legislative history quoted above suggests that Congress was particularly
concerned with that group of individuals, recognizing that disabled
individuals who follow their doctors' advice for dealing with their
disability should not be barred from the workplace simply for doing so. But
there is no connection between having a disability and distributing or
selling drugs, and no preclusion in the ADA of refusing to hire drug dealers
of any stripe.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Moreover, in the absence of any statutory provision addressing ADA
protection for drug dealers, the mode of analysis the majority
inappropriately applies to interpreting <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%20%2012210&amp;summary=yes#jcite">&sect; 12210</a> would have more force. That
is, absent any statutory provision addressing the intersection of the two
statutes, it would be proper to hold that employers may ban from employment,
and public entities may refuse to harbor within their borders, drug dealers
who violate the CSA, as Congress in no way indicated otherwise. That was the
mode of analysis adopted by the California Supreme Court in <i>Ross</i>, and which
I suggest would <span CLASS="page_no" data-cite="2012 bl 123718 p 17" data-cite-type="Bloomberg" data-cite-pageno="17" data-primary-citation="">[**17]</span> apply under the ADA to the question whether Title II
requires the Cities to allow the <i>distribution</i>&mdash; as opposed to the use &mdash; of
medical marijuana.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Deciding that question is, however, pre-mature at this juncture. The only
basis on which the preliminary injunction was denied was the district
court's conclusion that James was not within the group of disabled
individuals protected by Title II of the ADA. For now, I would simply decide
that question, holding that <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%20%2012210&amp;summary=yes#jcite">&sect; 12210</a> does not exclude James and the other
plaintiffs from the class of individuals protected
<span CLASS="page_no" data-cite="684 f 3d 844" data-cite-type="PrimaryFederalReporter" data-cite-pageno="844" data-primary-citation="684 F.3d 825">[*844]</span> 
by the ADA, and remand for further proceedings.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>4. Conclusion</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  While <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XEJKC6003?jcsearch=42%20U.S.C.%20%2012210(d)(1)&amp;summary=yes#jcite">&sect; 12210(d)(1)</a> has a degree of ambiguity, it is most naturally read
as carving out plaintiffs' medical marijuana use, which is "under
supervision by a licensed health care professional," from the ADA's "illegal
use of drugs" exception. The legislative history provides further support
for this interpretation. At the same time, it seems most likely that
Congress did not intend the ADA to require the Cities to permit marijuana
dispensaries, which remain illegal under the CSA, within their borders, as
the ADA provision at issue here is directed at personal use rather than
distribution. I therefore dissent with regard to Part I of the majority
opinion, and would remand for ultimate consideration on the merits of
whether James has alleged a viable cause of action with regard to the
<i>distribution</i>of drugs that are illegal under the CSA. I concur in the
remainder of the majority opinion.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn101" name="fn101">[fn1]</a></span> There is at least one CSA-authorized use that does not involve medical
supervision. <i>See</i><a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1976D2003?jcsearch=21%20U.S.C.%20%C2%A7%20829(c)&amp;summary=yes#jcite">21 U.S.C. &sect; 829(c)</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn201" name="fn201">[fn2]</a></span> This is not the place to enter into the contemporary debates &bull; about
the usefulness of legislative history in general, and of committee reports
in particular. <i>Compare Exxon Mobil Corp. v. Allapattah Services, Inc.</i>,
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XRI31VQNB5G0?jcsearch=545%20us%20546&amp;summary=yes#jcite">545 U.S. 546</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XRI31VQNB5G0?jcsearch=545%20us%20546&amp;summary=yes#jcite">568</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XRI31VQNB5G0?jcsearch=125%20supreme%20court%202611&amp;summary=yes#jcite">125 S.Ct. 2611</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XRI31VQNB5G0?jcsearch=162%20l%20ed%202d%20502&amp;summary=yes#jcite">162 L.Ed.2d 502</a> (2005) (Kennedy, J.)
("[J]udicial reliance on legislative materials like committee reports . . .
may give unrepresentative committee members &mdash; or, worse yet, unelected
staffers and lobbyists &mdash; both the power and the incentive to attempt
strategic manipulations of legislative history. . . .") <i>with </i><a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XRI31VQNB5G0?jcsearch=545%20U.S.%20546&amp;summary=yes#jcite">id.at 575-76</a>,
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XRI31VQNB5G0?jcsearch=125%20supreme%20court%202611&amp;summary=yes#jcite">125 S.Ct. 2611</a> (Stevens, J., dissenting) ("[C]ommittee reports are normally
considered the authoritative explication of a statute's text and purposes. .
. .") (citing <i>Garcia v. United States</i>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CB2K?jcsearch=469%20us%2070&amp;summary=yes#jcite">469 U.S. 70</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CB2K?jcsearch=469%20us%2070&amp;summary=yes#jcite">76</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CB2K?jcsearch=105%20supreme%20court%20479&amp;summary=yes#jcite">105 S.Ct. 479</a>,
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X5CB2K?jcsearch=83%20l%20ed%202d%20472&amp;summary=yes#jcite">83 L.Ed.2d 472</a> (1984)). Current Supreme Court precedent does permit
consideration of both where a statute is ambiguous, as it is here. <i>See</i>
<i>BedRoc Ltd. v. United States</i>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XRHNJ3QNB5G0?jcsearch=541%20us%20176&amp;summary=yes#jcite">541 U.S. 176</a>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XRHNJ3QNB5G0?jcsearch=541%20us%20176&amp;summary=yes#jcite">187</a> n. 8, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XRHNJ3QNB5G0?jcsearch=124%20supreme%20court%201587&amp;summary=yes#jcite">124 S.Ct. 1587</a>,
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XRHNJ3QNB5G0?jcsearch=158%20l%20ed%202d%20338&amp;summary=yes#jcite">158 L.Ed.2d 338</a> (2004). Moreover, statements made in the course of
legislative consideration are most useful where, as here, they do not in
terms declare any interpretive or application precept. Such self-conscious
declarations are indeed subject to manipulation by interest groups and may
represent a backdoor way to establish principles that would have failed if
included directly in the statute. <i>See Exxon Mobil</i>, <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XRI31VQNB5G0?jcsearch=545%20us%20546&amp;summary=yes#jcite">545 U.S. at 568</a>,
<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/XRI31VQNB5G0?jcsearch=125%20supreme%20court%202611&amp;summary=yes#jcite">125 S.Ct. 2611</a>. But statutory interpretation is aided rather than impeded by
such clues as one can find in the legislative materials concerning how the
legislators considering the bill were <i>speaking</i>about the statute at hand.
Ambiguous language can take on a more definite meaning in a particular
milieu. As a result, that sensitivity to the use of language while the bill
is being considered can illuminate apparent imprecisions in the
later-enacted statute. Pursuit of such a clarification is, to my mind, the
appropriate use of the bill sequence, hearings, and Committee report on
which I here rely.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn301" name="fn301">[fn3]</a></span> The Drug-Free Workplace Act requires that government contractors
ensure that their employees do not manufacture, distribute, dispense,
possess, or use controlled substances at work. See <a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1ERG3M003?jcsearch=41%20usc%208101&amp;summary=yes#jcite">41 U.S.C. &sect; 8101</a>-<a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1ERG40003?jcsearch=41%20U.S.C.%20%208106&amp;summary=yes#jcite">8106</a>.
</p></div>
<!--BBLS DD 1709749305347-->

</div>
<div class='sideBar printHide clearfix '>
<!-- /Default state -->
<!-- /Display properties -->
<div class='tabsNotepad printHide'>
<div class='tabButtons clearfix'>
<div class='borderTab activeTab' id='buttonTab_general'>
<span>
General Info
</span>
</div>
<div class='borderTab inactiveTab' id='buttonTab_notePad'>
<span>Notepad</span>
</div>
</div>
</div>
<div class='sideBarInner clearfix'>
<div class='sideBarContent bootstrap sidebar ' id='tab_general'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span class='left'>BCite Analysis</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider bciteRenderer clearfix'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1HOAG0003/history">Direct History (3)</a>
</div>
<div class='sidebarItemLabel bold'>
No Negative Direct History
</div>
</div>
<div class='bciteRenderer clearfix sidebarSectionDivider sidebarSubsection'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1HOAG0003/analysis">Case Analysis (0)</a>
</div>
<div class='sidebarItemLabel bold'>
No Citing Court Opinions
</div>
</div>
<div class='sidebarSubsection clearfix analysisLink'>
<div class='sidebarSubhead small'>
<a href="https://www.bloomberglaw.com/help/BCite_Indicators.htm" class="citatorRenderer">Description of BCite Indicators</a>
</div>
</div>

<div id='generalInfo'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span>
General Information
</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Result(s)</div><div class='facetItemLabel'>Judgment Affirmed</div></div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Related Docket(s)</div><div class='facetItemLabel'><a href="/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/document/X1Q6LBCV8DO2">10-55769 (9th Cir.)</a></div></div><div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Topic(s)</div><div class='facetItemLabel'>Constitutional Law</div><div class='facetItemLabel'>Criminal Law</div><div class='facetItemLabel'>Employment Law</div><div class='facetItemLabel'>Government</div><div class='facetItemLabel'>Health Law</div></div>
<div class='sidebarSubsection' id='judges_section'>
<div class='facetItemHeading'>Judge(s)</div>
<div id='judges_section_loader'></div>
</div>
</div>
</div>
</div>
</div>
<div class='sideBarContent clearfix notepad hidden' id='tab_notePad'>
<div id='notepad'>
<div class='notepadInstructions'>
Click anywhere in Notepad to add a note.
</div>
<div class='protoNote note'>
<a class='anchor'></a>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
<div class='ieFloat right'>
<a class='delete'>
Delete
</a>
<div class='toolDivider'>
|
</div>
<a class='edit'>
Edit
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='body'></div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay'></span>
</div>
<div class='ieFloat right'>
<a class='next'>
Next
</a>
</div>
</div>
</div>
<div class='protoNoteEditor note'>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
</div>
<div class='body'>
<textarea class='contents'></textarea>
<div class='toolRow'>
<a class='save'>
Save
</a>
<div class='toolDivider'>
|
</div>
<a class='cancel'>
Cancel
</a>
<div class='clearfix'></div>
</div>
</div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous disabled'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay disabled'></span>
</div>
<div class='ieFloat right'>
<a class='next disabled'>
Next
</a>
</div>
</div>
</div>
<div class='protoConfirmDelete'>
<div class='popupWindowOuter'>
<div class='popupWindowInner'>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>
Delete Note
</h2>
</div>
<div class='popupContent'>
<div class='sectionLabel'>
Are you sure you want to delete this note?
<br>
<br>
<br>
<br>
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right'>
<span>
Delete
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup()'>
<span>
Cancel
</span>
</button>
</div>
</div>
</div>
</div>
</div>

</div>
</div>

</div>
<div class='clearfix'></div>
</div>

<div class='keywordSearch' id='keyword_search'>
<a href="javascript:Blaw__findPrevKeyWord();redrawPrevNextButtons();" id="keyword_search_previous">Previous Keyword</a>
|
<a href="javascript:Blaw__findNextKeyWord();redrawPrevNextButtons();" id="keyword_search_next">Next Keyword</a>
</div>
<div class='pageLoader'></div>
<div class='browserPopupContainer' id='browserPopup'>
<div class='browserTitle'>
<div class='close' onclick='$("#browserPopup").bbTocBrowser(false);'></div>
<h2 class='popup_title'></h2>
</div>
<div class='browserPopupContent popup_content' id='browserPopupContent'></div>
</div>
<div class='maskOverlay' id='ajax_browser_mask'></div>


<div class='clearfix'></div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->
<div class='clientMatterContainer hidden' id='clientMatterContainer'>
<form accept-charset="UTF-8" action="/client_matter/session/create" id="startClientMatterSessionForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id="create_client_matter" name="create_client_matter" type="hidden" value="false" />
<div class='clearfix popupTitle'>
<div class='close' onclick='cancelClientMatterPopup()'></div>
<h2>
Enter a Client Matter
</h2>
</div>
<div class='popUpContent'>
<div class='clientMatterPopupHeader'>
Your firm optionally allows a client matter to be selected while you are using Bloomberg Law.
Please select from a recently used Client Matter or enter a Client Matter manually.
</div>
<div class='error' id='clientMatterLabelErrors' style='display:none'></div>
<div class='error' id='attorneyNumberLabelErrors' style='display:none'></div>
<div class='row sources clearfix'>
<div class='labelHolder'>
<span class='label'>Client Matter</span>
</div>
<div class='inputContainer'>
<input autocomplete="off" class="autocompleteTextField input_auto autocompleteForm" data-context="CLIENT_MATTERS" data-highlight-term="true" data-select-callback="applyClientMatterFromAutocompleteSelection" data-show-no-matches="false" data-url="/autocomplete/lookup" id="client_matter_label" name="client_matter_label" type="text" value="" />
<script type="text/javascript">
//<![CDATA[
jQuery().ready(function ($) { $('#client_matter_label').bbAutocomplete(); });
//]]>
</script>
</div>
</div>
<div class='row clientMatterSuppressionCheckholder' id='clientMatterSuppressionCheckholder'>
<label>
<input id="suppress_client_matter_prompt_enabled" name="suppress_client_matter_prompt_enabled" type="hidden" value="1" />
<input checked="checked" id="suppress_client_matter_prompt" name="suppress_client_matter_prompt" type="checkbox" value="1" />
<label for="suppress_client_matter_prompt">Do not remind me again this session</label>
</label>
</div>
<div class='clientMatterText'>
Please contact your administrator if you have questions about client matter.
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup right' type='submit'>
<span>
Submit
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='cancelClientMatterPopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

<div id='createClientMatterForm' style='display:none'>
<div class='clearfix popupTitle'>
<h2>
Unrecognized Client Matter
</h2>
</div>
<div class='div'>
Client Matter
<span id='new_client_matter_label'>&nbsp;</span>
does not currently exist in Bloomberg Law. Would you like to add this client matter to the system?
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' type='button'>
<span>
Yes
</span>
</button>
<button class='bootstrap skinButton popup cancel right' type='button'>
<span>
No
</span>
</button>
</div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->

<div id='loading_container'></div>
<div class='fixedControls menuHolder printHide' id='bottom_menu_row'>
<div class='menuButton' id='pde_tray_menu'>
<div class='queueImageHolder'></div>
<div class='indicator num_of_pde_tray_items'></div>
</div>
<div class='clearfix'></div>
</div>
<div class='menuItem bottomMenu' id='pde_tray'>
<div class='inner'>
<div class='heading'>
<div class='title'>
Queue
<span class='indicator num_of_pde_tray_items'></span>
<!-- =pde_tray_count_from_session -->
</div>
<div class='bootstrap closeIcon right' id='pde_tray_close_button'></div>
<div class='clearfix'></div>
</div>
<div class='actions hasItems' id='pde_tray_has_items'>
<div class='selection'>
<div class='trayCheckHolder'>
<input id='pde_tray_select_all' type='checkbox'>
</div>
Select All
</div>
<div class='tools'>
<a onclick='javascript:PDETray_default.downloadSelection();'>
Print/Download
</a>
|
<a onclick='javascript:PDETray_default.emailSelection();'>
Email
</a>
|
<a onclick='javascript:PDETray_default.workspaceSelection();'>
+ Workspace
</a>
|
<a onclick='javascript:PDETray_default.deleteSelection();'>
Delete
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='actions noItems' id='pde_tray_no_items'>
<div class='title'>
You have no items in your Queue
</div>
<div class='clearfix'></div>
</div>
<div class='itemsHolder' id='pde_tray_items'></div>
</div>
</div>

<div class='maskOverlay' id='pde_tray_mask'></div>

<script language='javascript'>
var SHOW_AUDIT = false;
var ROOT_PATH = "/";
var RAILS_ROOT = "/";
var CONTEXT_PATH = "/";
var DOC_ROOT_PATH = "/s/opinion/2cca9bfdd71c4fe272702f69d32bd070/";
var RESULTS_ROOT_PATH = "/search/results/";
var SELECTED_CONTEXT = "";
var MODULE_PATH;
MODULE_PATH = "/document";
var CRUMB_ID = "2cca9bfdd71c4fe272702f69d32bd070";
var BILLING_CONFIGURATION = {"DOCKET":true,"NEWS":false,"LAW":true,"ADVANCED_LEGAL":true,"PATENT":true,"PATENT_ASSIGNMENT":true,"PEOPLE":false,"OPINION":true,"CITATION":false,"BREAKING":true,"DOCKET_REQUESTS":true,"COMPANY_FILINGS_EDGAR":false,"COMPANY_FILINGS_DOCKETS":false,"COMPANY_FILINGS_OTHER":false,"CORP_ACTIONS":true,"ECO_SEARCH":true,"EDGAR_SEARCH":true,"EXAMPLE_DOCUMENTS":true,"CLAUSE_SEARCH":true,"LEG":true,"REG":true,"BOOLEAN":false,"SIMPLE":false,"COMPANY_DOCKETS":true,"TOC_SEARCH":true,"IMMUTABLE_LAW_SEARCH":true};
var CONTEXT_BILLING_POLICY_KEY = "";
var ELITE_ENABLED = false;
var CLIENT_MATTER_PROMPT_ENABLED = false;
var CLIENT_MATTER_ON_LOGIN_ENABLED = false;
var SUPPRESS_CLIENT_MATTER_PROMPT = false;
var clientMatterActive = false;
var currentClientMatter = '';
var currentAttorneyNumber = '';
var clientMatterHaltedForm = null;
var USER_ID = 'un=373038066';
var SESSION_ID = '63166_a5929cc15e1bfd637ed52768bec5d196';
var NTPT_REDIRECTED_EVENT = '';
var NTPT_PGEXTRA = '&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITY308798&previousPageId=&previousActivityInstanceId=ENTITYc86627&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T00:56:50-05:00';
var NTPT_GLBLEXTRA = 'un=373038066&sessionId=63166_a5929cc15e1bfd637ed52768bec5d196&auth=true';
var BROWSER_COMPATIBILITY_WARNING = 'false';
var SHOW_MODAL = false;
var JUG;
$(document).ready(function(){
setTimeout(framework_getPageState,500);
framework_bindGlobalResizeElements();
notepad_onDocumentLoaded();
<!-- /DRQS 24932463 -->
$("#downloadPopupLinkForm a").removeAttr("href");
$('#startClientMatterSessionForm').submit(function() {
  createClientMatterSessionFromForm(this);
  return false;
});

var t = $('.clientMattersTableEl');

jQuery.each(t, function(name, value) {
  try {
    var this_value =  $.trim(String(value.innerHTML));
    var this_final_value = this_value.length > 22 ? this_value.substring(0,9)+"..." : this_value;
    value.innerHTML = this_final_value;
  } catch (e) {}
});

$('#startClientMatterSessionForm .recentlyUsed td').click(function() {
  $('#client_matter_label').val($.trim($(this).attr("title")));
});

});
</script>
<script type='text/javascript'>
DOCUMENT_SHOW_SIDEBAR="true";
DOCUMENT_HAS_SIDEBAR_INFO="true";
DOCUMENT_IS_IFRAME="";
NTPT_PGEXTRA = 'documentSearchType=OPINION&docId=X1HOAG0003&docType=OPINIONS&contentClass=LEGAL&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITYc86627&previousPageId=&previousActivityInstanceId=ENTITY19cc73&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T00:56:48-05:00';
FLUID_LAYOUT="false";
FULL_DOC_ID = 'X1HOAG0003';
NOTEPAD_UUID="11082191";
NOTEPAD_DOC_ID="X1HOAG0003";
$('#page_loader').show().spin();
JUDGE_IDS=["2012863","2397859"];
JUDGE_NAMES=null;
</script>

<script src="/javascripts/activity_tracking/ni.js?1376494218" type="text/javascript"></script>
<script src="/javascripts/activity_tracking/tracking.js?1384975732" type="text/javascript"></script>
<div class='footer'>
<div class='footerContent printHide'>
<div class='logoContainer grid eight'>
<div class='copyright'>
&copy; 2014 The Bureau of National Affairs, Inc. All Rights Reserved.
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPR08'); return false;">Terms of Service</a>
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPH08'); return false;">Privacy Policy</a>
</div>
<a class='logo' href='/home'></a>
<div class='version'>
2.
231154
Gem
0.176.7
231497
 - 3.0.20
</div>
<div class='helpContainer'>
<div class='helpDesk'></div>
<a href="/help/BLAWHelpSystem.htm#Contact_Us.htm" class="menuLink">Submit Feedback</a>
 | 
<a href="mailto:blawhelp@bna.com" class="menuLink">blawhelp@bna.com</a>
</div>
</div>
</div>

</div>
</div>
</body>
</html>
